Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027953	s-aldol	u/l (u/l)	2013	2902	0.03%
3027953	s-aldol	— (—)	503	587	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Oral corticosteroids

930

1246

4.56

319.07

1.9

1.2

6.05

5.89

u/l

0.16

780

1043

Other soft tissue disorders, not elsewhere classified

802

993

5.04

309.64

1.5

1.3

5.53

6.03

u/l

0.61

670

834

Diseases of the myoneural junction and muscle

279

199

14.82

308.11

1.9

1.4

8.97

6.50

u/l

1.10

227

169

Symptoms and signs involving the nervous and musculoskeletal systems

639

1142

5.69

307.65

1.4

1.5

5.33

5.94

u/l

1.03

521

976

Other systemic involvement of connective tissue

476

448

11.00

307.65

1.8

1.2

5.61

6.03

u/l

0.34

408

370

Other systemic involvement of connective tissue (FG)

466

340

14.11

307.65

1.8

1.3

5.62

6.23

u/l

0.40

398

277

ILD medications: immunosuppressive drugs

640

1021

6.10

307.65

2.2

1.1

6.20

6.12

u/l

0.06

562

852

Systemic connective tissue disorders

682

593

11.95

307.65

2.1

1.2

6.08

5.89

u/l

0.16

595

491

ILD medications

936

1173

4.42

297.24

1.8

1.1

5.86

6.00

u/l

0.13

794

974

ILD medications: prednisolone, methylprednisolone, prednisone

908

1156

4.48

296.51

1.8

1.1

6.00

6.01

u/l

0.01

765

958

Inflammatory bowel disease treatment related agents

945

1284

4.22

288.45

1.8

1.2

6.09

5.89

u/l

0.22

795

1077

Myositis

155

55.73

270.24

3.2

1.3

9.34

5.65

u/l

3.14

148

Disorders of muscles

215

125

18.03

263.95

2.7

1.4

8.46

5.93

u/l

2.18

194

106

First line medication for Crohn's disease

868

1158

4.12

253.52

1.8

1.2

5.91

5.97

u/l

0.05

736

967

Myalgia

301

329

9.38

249.64

1.4

5.00

5.88

u/l

1.16

247

282

Other and unspecified myopathies

199

118

17.89

242.38

2.0

1.5

9.67

7.35

u/l

0.63

167

Reimbursement for rheumatic diseases

562

1208

4.71

240.20

2.2

1.2

5.89

5.77

u/l

0.14

489

1009

Pain in joint

506

563

6.02

240.12

1.4

1.5

5.16

6.56

u/l

2.62

419

480

Autoimmune diseases related-to ILD

708

1557

4.04

239.86

1.9

1.2

6.07

5.82

u/l

0.30

604

1289

Other symptoms and signs involving the nervous and musculoskeletal systems

447

803

5.67

235.72

1.4

1.5

5.11

5.93

u/l

1.86

367

685

Finngen Rheumatological endpoints

759

1034

4.22

232.40

1.7

1.2

5.82

6.15

u/l

0.34

654

850

L04AX Other immunosuppressants

531

1205

4.47

212.88

2.3

1.2

6.26

5.69

u/l

0.93

463

1017

Pain in limb

580

951

4.45

208.13

1.5

1.3

5.78

6.06

u/l

0.24

488

797

Second line medication for Crohn's disease

535

1250

4.34

206.56

2.3

1.2

6.26

5.65

u/l

1.04

467

1051

Mixed connective tissue disease

179

124

15.48

201.39

2.1

1.4

6.14

6.12

u/l

0.01

159

105

Other specific joint derangements/joint disorders

587

958

4.15

187.71

1.4

1.5

5.22

6.52

u/l

2.52

489

793

Polymyositis

114.32

181.76

4.1

1.2

9.26

5.42

u/l

1.79

Polymyalgia rheumatica

184

165

11.53

176.04

1.5

1.2

5.24

6.47

u/l

0.61

152

139

Other specified/unspecified systemic involvement of connective tissue

149

16.89

176.02

2.0

1.2

5.67

5.68

u/l

0.01

133

Autoimmune diseases excluding thyroid diseases

739

1194

3.46

172.94

1.9

1.2

6.37

5.70

u/l

0.89

640

992

Soft tissue disorders

699

1002

3.65

171.60

1.6

1.3

6.03

u/l

0.00

592

843

Autoimmune diseases excluding thyroid diseases, strict definition

713

1158

3.46

166.82

1.9

1.2

6.41

5.70

u/l

0.94

617

965

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

122

26.99

141.79

2.2

1.0

6.02

5.06

u/l

0.77

109

Neurological diseases, wide definition

209

13.05

140.69

1.6

1.0

6.63

5.07

u/l

1.24

172

Other dorsopathies, not elsewhere classified

668

1091

3.25

140.20

1.5

1.4

5.70

6.40

u/l

0.84

562

914

Dorsalgia

651

1087

3.26

138.85

1.5

1.4

5.50

6.40

u/l

1.25

549

910

Spondylopathies

533

904

3.61

137.06

1.4

5.53

6.50

u/l

1.19

449

760

Diseases of the musculoskeletal system and connective tissue

316

267

5.97

130.23

1.6

1.1

6.79

7.39

u/l

0.17

270

216

General symptoms and signs

709

1185

3.02

129.95

1.5

1.4

5.76

5.80

u/l

0.04

601

995

Malaise and fatigue

361

715

4.25

128.85

1.5

1.4

5.22

5.82

u/l

1.22

297

599

Low back pain

475

1058

3.48

125.85

1.4

5.54

6.43

u/l

1.01

401

886

Neurological diseases

545

787

3.51

125.51

1.6

1.4

6.06

5.47

u/l

0.69

463

662

Abnormalities of gait and mobility

153

173

9.11

123.93

1.5

1.4

5.97

6.53

u/l

0.17

119

149

Other arthritis (FG)

240

453

5.37

120.06

1.5

1.3

5.63

6.19

u/l

0.45

203

383

Autoimmune diseases

676

1198

2.90

116.88

1.8

1.2

6.42

5.70

u/l

0.85

580

995

Dorsopathies

634

1101

2.96

113.30

1.5

1.4

5.74

6.40

u/l

0.76

537

923

Polyarthropathies

448

865

3.48

113.07

1.6

1.5

5.64

6.67

u/l

1.45

377

716

Fever of other and unknown origin

362

906

3.74

112.26

1.7

1.4

5.91

5.88

u/l

0.03

299

765

Spondylosis

352

791

3.85

111.35

1.4

5.26

6.70

u/l

2.45

305

666

Other intervertebral disc disorders

513

999

3.16

109.06

1.5

1.4

5.47

6.48

u/l

1.36

436

840

Lower back pain or/and sciatica

650

1694

2.68

107.40

1.5

1.4

5.39

6.10

u/l

1.21

552

1412

Used for control exclusion in common control thyroid runs

622

1107

2.86

105.23

1.8

1.2

6.12

5.74

u/l

0.38

538

925

ILD medications: azathioprine

155

217

7.28

104.81

2.9

1.1

6.81

6.21

u/l

0.35

132

185

Other and unspecified polyneuropathies, also in other diseases

187

326

5.85

102.23

1.5

1.4

5.31

6.64

u/l

1.28

156

270

Fibromyalgia

115

10.28

102.06

1.4

4.76

5.56

u/l

1.18

100

Polyneuropathies and other disorders of the peripheral nervous system

202

389

5.29

99.09

1.5

5.41

6.48

u/l

1.17

170

328

Azathioprine

155

234

6.75

97.78

2.9

1.2

6.81

5.78

u/l

0.82

132

200

Abnormalities of breathing

563

1194

2.82

97.75

1.5

6.03

5.85

u/l

0.13

479

1010

Pain (limb, back, neck, head abdominally)

414

588

3.55

96.85

1.4

1.5

6.08

6.52

u/l

0.31

360

502

Other specified/unspecified arthritis

215

447

4.87

96.37

1.5

5.67

6.32

u/l

0.64

180

381

Sicca syndrome [Sjögren]

115

126

9.41

95.49

1.9

1.2

5.78

5.60

u/l

0.09

107

Headache

396

1051

3.17

92.95

1.4

6.22

5.85

u/l

0.20

339

883

Sciatica+with lumbago

316

857

3.53

90.85

1.6

1.4

5.04

6.63

u/l

3.28

274

726

Other joint disorders

519

979

2.84

88.15

1.4

1.5

5.23

6.50

u/l

2.50

443

810

Care involving use of rehabilitation procedures

424

1405

2.89

87.32

1.7

1.4

5.47

6.01

u/l

0.99

355

1202

Examination and observation for other reasons

367

663

3.39

86.59

1.5

1.4

5.77

5.93

u/l

0.13

299

564

Tramadol

479

1096

2.83

85.77

1.5

1.4

6.67

5.80

u/l

0.69

405

916

Arthropathies

533

986

2.77

85.14

1.5

5.87

6.51

u/l

0.61

453

817

Medical observation and evaluation for suspected diseases and conditions

413

666

3.19

83.87

1.4

6.43

5.93

u/l

0.36

350

567

Nerve, nerve root and plexus disorders

625

1621

2.44

83.27

1.6

1.4

5.89

5.94

u/l

0.04

519

1359

Asthma

473

893

2.86

81.48

1.5

1.4

5.33

5.94

u/l

1.30

393

761

Asthma, excluding more controls

463

867

2.86

79.87

1.5

1.3

5.35

5.93

u/l

1.16

386

738

Infections, IBD-co-morbidities

12.97

77.73

1.8

1.0

6.16

4.86

u/l

0.89

Asthma (mode)

458

900

2.81

77.32

1.5

1.4

5.31

5.94

u/l

1.40

381

768

Spinal stenosis

285

641

3.51

77.11

1.5

1.4

5.73

6.53

u/l

0.57

241

536

Dermatitis

377

1335

2.85

76.57

1.5

5.25

6.07

u/l

2.05

320

1113

Disorders of thyroid, IBD co-morbidities

11.45

74.28

1.6

1.0

5.87

4.85

u/l

0.70

Pain, not elsewhere classified

196

467

4.24

74.15

1.6

1.5

5.00

5.95

u/l

2.17

165

399

Pain in throat and chest

484

1144

2.60

73.17

1.4

5.87

5.85

u/l

0.01

419

963

Other and unspecified primary disorders of muscles

39.58

73.07

1.5

1.6

7.40

8.33

u/l

0.11

Shoulder lesions

391

828

2.91

72.62

1.4

1.3

5.59

6.08

u/l

0.50

337

700

Abnormal involuntary movements

125

206

6.19

72.50

1.4

1.5

4.98

6.39

u/l

1.74

100

177

Other and unspecified dermatitis

325

1119

2.93

69.62

1.5

5.29

6.01

u/l

1.61

280

940

Symptoms and signs involving the circulatory and respiratory systems

571

1201

2.39

68.84

1.5

5.73

5.84

u/l

0.11

475

1015

Opioids

555

1217

2.41

68.57

1.4

5.82

5.74

u/l

0.07

468

1012

Codeine

530

1200

2.44

68.33

1.5

1.4

5.58

5.74

u/l

0.23

458

997

Lumbar disc prolapse

342

950

2.88

67.34

1.5

1.4

5.70

6.55

u/l

0.76

289

803

Other/unspecified dorsalgia

218

602

3.63

66.47

1.5

1.4

5.67

6.01

u/l

0.17

183

510

Episodal and paroxysmal disorders

614

1409

2.24

64.59

1.5

5.57

5.86

u/l

0.38

521

1171

Dyspnoea

495

1623

2.35

64.27

1.5

1.4

5.79

6.04

u/l

0.25

423

1351

Symptoms and signs involving the skin and subcutaneous tissue

405

1620

2.50

63.94

1.5

1.4

5.47

5.92

u/l

0.49

342

1360

Dermatopolymyositis, unspecified

163.27

63.78

4.0

1.3

6.58

5.50

u/l

—

Asthma (only as main-diagnosis)

395

893

2.68

63.29

1.5

1.4

5.42

5.94

u/l

1.01

326

761

Asthma (only as main-diagnosis), excluding more controls

391

867

2.70

63.20

1.5

1.3

5.41

5.93

u/l

0.96

323

738

SLE (Finngen)

13.66

62.52

1.9

1.1

5.94

6.14

u/l

0.05

L04AA Selective immunosuppressants

188

494

3.86

62.40

2.5

1.5

6.12

u/l

0.00

168

417

Other necrotizing vasculopathies (FG)

11.73

62.17

1.4

1.3

5.13

8.32

u/l

0.57

ILD, hospital admissions

127

247

5.23

61.79

2.1

1.5

5.99

6.67

u/l

0.37

112

209

Dermatitis and eczema

588

1789

2.16

60.81

1.4

5.40

6.06

u/l

1.21

501

1490

General examination and investigation of persons without complaint and reported diagnosis

354

665

2.85

60.73

1.3

1.4

5.50

5.93

u/l

0.28

298

566

Interstitial lung disease endpoints

127

251

5.15

60.67

2.1

1.5

5.99

6.73

u/l

0.41

112

213

Interstitial lung disease

127

251

5.15

60.67

2.1

1.5

5.99

6.73

u/l

0.41

112

213

Other interstitial pulmonary diseases

127

251

5.15

60.67

2.1

1.5

5.99

6.74

u/l

0.42

112

213

Other necrotizing vasculopathies

8.34

59.11

1.6

1.3

5.18

6.72

u/l

0.46

Asthma, unspecified (mode), excluding more controls

291

786

2.92

58.86

1.5

1.3

5.40

5.97

u/l

0.96

235

670

ILD, hospital admissions 1, main diag only

117

221

5.40

58.85

2.2

1.6

5.96

6.77

u/l

0.41

103

188

Persons encountering health services for specific procedures and health care

587

1702

2.15

58.61

1.7

1.4

5.90

5.88

u/l

0.02

487

1436

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

189

215

4.43

58.53

1.5

1.3

6.79

6.25

u/l

0.19

159

190

Asthma, unspecified (mode)

292

804

2.90

58.21

1.5

1.4

5.39

5.86

u/l

0.83

236

685

Asthma-related infections

333

1266

2.60

57.00

1.5

5.41

6.00

u/l

1.42

275

1081

Asthma, hospital admission 2, infections

333

1266

2.60

57.00

1.5

5.41

6.00

u/l

1.42

275

1081

Rotator cuff syndrome

293

769

2.85

55.66

1.4

1.3

5.54

6.18

u/l

0.61

247

652

274

966

2.83

55.40

1.5

1.4

5.35

6.11

u/l

1.56

230

827

Systemic lupus erythematosus

11.17

55.11

1.9

1.2

5.94

6.32

u/l

0.13

Anxiety disorders, excluding more controls

464

1352

2.29

54.90

1.5

5.60

5.70

u/l

0.07

395

1142

Rheumatism, unspecified

108

203

5.40

54.57

1.4

1.5

4.85

6.15

u/l

1.07

169

Parasetamol

430

903

2.44

54.48

1.5

1.4

6.06

6.43

u/l

0.26

363

772

Excluding asthma or asthma-COPD overlap

435

901

2.43

54.23

1.6

1.4

5.84

5.94

u/l

0.07

367

768

Codeine or tramadol medication

607

1626

2.08

54.22

1.5

1.4

5.90

5.94

u/l

0.03

521

1352

Other respiratory diseases principally affecting the interstitium

135

309

4.43

54.02

2.1

1.5

5.98

6.74

u/l

0.51

118

258

Other pulmonary diagnosis

434

901

2.42

53.85

1.6

1.4

5.84

5.94

u/l

0.07

365

768

Asthma (diagnoses ohter than nonallergic)

464

1803

2.21

53.77

1.5

5.34

6.08

u/l

2.15

381

1514

Hypothyroidism (congenital or acquired)

169

228

4.29

53.52

1.7

1.4

5.27

5.10

u/l

0.18

138

206

ILD differential diagnosis

432

900

2.41

53.21

1.6

1.4

5.85

5.94

u/l

0.06

365

768

Other antidepressants

552

1343

2.15

53.17

1.4

1.5

6.02

6.04

u/l

0.01

461

1126

COPD differential diagnosis

431

901

2.41

52.72

1.6

1.3

5.85

5.94

u/l

0.07

364

769

Migraine

292

920

2.72

52.69

1.4

1.5

4.86

5.85

u/l

3.01

240

775

Diseases of the skin and subcutaneous tissue

533

1231

2.18

52.30

1.5

1.4

5.89

6.21

u/l

0.26

454

1029

Mood disorders, excluding more controls

509

1438

2.16

51.73

1.5

1.4

5.96

5.86

u/l

0.07

412

1212

Dysphagia

161

434

3.75

51.52

1.7

1.4

5.68

6.63

u/l

0.72

139

360

Abnormal findings on examination of blood, without diagnosis

268

912

2.77

51.27

1.7

1.4

5.92

6.21

u/l

0.30

223

772

GASTRO-related operations

436

937

2.34

50.52

1.6

1.3

6.45

5.48

u/l

1.13

365

808

Any gastric operation

436

937

2.34

50.52

1.6

1.3

6.45

5.48

u/l

1.13

365

808

Hypothyroidism, levothyroxine purchases

164

227

4.18

50.50

1.7

1.4

5.33

5.09

u/l

0.25

133

205

Hypothyroidism and >3 levothyroxin purchases

164

227

4.18

50.50

1.7

1.4

5.33

5.09

u/l

0.25

133

205

Diseases of oesophagus, stomach and duodenum

559

1657

2.06

50.05

1.4

6.02

5.90

u/l

0.09

466

1402

Neurotic, stress-related and somatoform disorders

487

1632

2.13

49.54

1.4

1.5

5.57

5.88

u/l

0.26

412

1379

Anxiety disorders

490

1643

2.12

49.36

1.4

1.5

5.58

5.88

u/l

0.26

415

1386

Cardiovascular diseases

351

756

2.54

49.31

1.5

1.4

5.99

5.34

u/l

0.83

301

644

Any reimbursement code in KELA

319

595

2.70

48.88

1.6

1.2

6.27

5.77

u/l

0.34

272

511

Anaemias

143

221

4.34

48.71

1.4

1.5

6.16

5.14

u/l

0.51

120

202

Mood [affective] disorders

539

1745

2.04

48.11

1.4

1.5

5.98

5.89

u/l

0.06

434

1485

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

460

1330

2.18

47.88

1.6

1.4

6.11

5.99

u/l

0.09

378

1113

460

1330

2.18

47.88

1.6

1.4

6.11

5.99

u/l

0.09

378

1113

Mood disorders

539

1748

2.03

47.69

1.4

1.5

5.98

5.89

u/l

0.06

434

1488

Disturbances of skin sensation

192

610

3.18

47.60

1.2

1.5

4.75

5.68

u/l

2.68

162

519

Disorders of synovium and tendon

246

798

2.79

47.49

1.3

5.52

5.91

u/l

0.33

210

668

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

501

1742

2.07

47.41

1.6

1.4

5.78

5.98

u/l

0.20

414

1473

Systemic atrophies primarily affecting the central nervous system

9.66

47.36

1.1

1.5

5.34

9.01

u/l

0.66

Asthma, including avohilmo

600

1777

1.97

47.19

1.4

1.5

5.52

6.03

u/l

0.68

497

1498

Metabolic disorders

490

1464

2.09

45.89

1.5

1.4

6.12

5.80

u/l

0.31

411

1236

Depression

504

1703

2.05

45.86

1.4

1.5

5.86

5.87

u/l

0.01

406

1452

ILD, hospital admission 2, with pulmonary infections

135

6.03

45.41

2.2

1.5

6.16

6.66

u/l

0.22

119

Hypothyroidism, strict autoimmune

337

927

2.42

45.27

1.4

1.2

5.92

5.62

u/l

0.22

272

765

Temporomandibular joint disorders

185

5.13

45.11

1.4

1.6

5.28

7.51

u/l

1.49

159

Other special examinations and investigations of persons without complaint or reported diagnosis

330

666

2.52

44.56

1.5

1.4

5.75

5.93

u/l

0.15

283

567

Depression medications

175

238

3.72

44.11

1.5

5.86

5.08

u/l

0.63

150

215

Antihypertensive medication - note that there are other indications

342

773

2.43

44.08

1.5

1.4

6.68

5.61

u/l

0.86

293

652

Symptoms and signs concerning food and fluid intake

139

5.76

42.86

1.4

1.3

6.90

7.19

u/l

0.05

120

Chronic lower respiratory diseases

608

1739

1.90

42.31

1.5

5.88

5.93

u/l

0.03

499

1475

Influenza and pneumonia

533

1802

1.95

42.21

1.7

1.4

6.39

5.78

u/l

0.58

442

1523

Cervical disc disorders

184

612

3.03

42.17

1.3

1.4

5.22

6.15

u/l

1.82

150

520

COPD/asthma/ILD related infections

530

1331

2.00

42.00

1.5

1.4

5.84

5.99

u/l

0.13

442

1113

COPD/asthma related infections

530

1331

2.00

42.00

1.5

1.4

5.84

5.99

u/l

0.13

442

1113

Somatoform disorder

129

345

3.79

41.91

1.5

1.4

5.10

6.48

u/l

1.47

113

288

Other enthesopathies

155

468

3.34

41.78

1.2

1.3

4.96

5.71

u/l

1.32

131

404

Cervicobrachial syndrome

129

346

3.76

41.66

1.3

1.5

5.69

6.42

u/l

0.43

108

297

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

123

6.05

41.55

1.6

1.4

6.23

7.38

u/l

0.36

107

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

323

1316

2.29

41.37

1.6

1.4

6.49

5.94

u/l

0.40

280

1098

Deforming dorsopathies

147

433

3.42

41.22

1.8

1.5

4.85

6.13

u/l

2.30

126

364

Rheumatoid arthritis

168

483

3.18

40.99

1.8

1.6

5.64

6.21

u/l

0.65

144

406

Other headache syndromes

232

890

2.62

40.68

1.3

1.4

4.98

5.96

u/l

2.82

200

743

Oedema, not elsewhere classified

161

508

3.18

40.00

1.7

1.4

6.55

5.95

u/l

0.25

135

424

Symptoms and signs involving cognition, perception, emotional state and behaviour

481

1714

1.97

39.95

1.4

6.61

5.76

u/l

0.65

404

1436

L04AD Calcineurin inhibitors

226

4.46

39.93

3.0

1.4

6.32

7.35

u/l

0.45

190

Non-invasive ventilation

130

337

3.65

39.61

1.5

1.3

7.43

5.54

u/l

0.77

107

288

Pain in thoracic spine

213

4.51

39.10

1.2

1.5

5.06

6.01

u/l

1.43

182

Symptoms and signs involving the digestive system and abdomen

496

1255

1.99

38.64

1.6

1.5

5.64

6.14

u/l

0.72

421

1065

Cervicalgia

114

296

3.89

38.60

1.2

1.5

5.54

6.59

u/l

0.69

248

SLE, ICD10

7.79

38.41

1.8

1.4

5.68

6.79

u/l

0.47

SLE, strict definition

7.79

38.41

1.8

1.4

5.68

6.79

u/l

0.47

Cramp and spasm

6.94

37.47

1.3

1.5

5.20

8.72

u/l

1.02

Gastro-oesophageal reflux disease

342

1418

2.15

37.30

1.4

5.14

5.92

u/l

1.81

283

1211

Cardiac arrhythmias

336

1007

2.22

37.17

1.4

6.21

5.37

u/l

0.88

285

856

Recurrent or chronic depression

225

619

2.64

37.13

1.3

1.5

6.75

5.64

u/l

0.42

178

527

Giant cell arteritis

9.08

36.45

1.1

5.16

5.15

u/l

0.01

Soft tissue disorders related to use, overuse and pressure

129

381

3.41

36.09

1.7

1.4

5.05

6.02

u/l

1.40

107

325

Persons encountering health services for examination and investigation

310

666

2.34

36.08

1.5

1.4

6.36

5.93

u/l

0.26

270

567

Other specified disorders of muscle

10.88

35.92

1.8

1.3

8.43

5.51

u/l

0.71

Small fibre neuropathy

9.19

35.67

1.5

1.3

5.41

6.43

u/l

0.42

Gonarthrosis [arthrosis of knee](FG)

304

783

2.29

35.44

1.4

1.2

5.81

6.35

u/l

0.44

257

647

Disorders of other endocrine glands

238

971

2.43

35.38

1.4

1.5

5.68

5.99

u/l

0.18

198

813

Abdominal and pelvic pain

482

1255

1.94

35.08

1.4

1.5

5.51

6.14

u/l

1.04

404

1065

Asthma, hospital admissions , main diagnosis only

404

1845

1.97

35.02

1.5

5.43

6.04

u/l

1.54

335

1550

Dizziness and giddiness

365

1450

2.05

34.86

1.4

6.29

5.71

u/l

0.41

309

1217

Depression or dysthymia

346

897

2.17

34.82

1.5

6.30

6.06

u/l

0.11

289

756

Carpal tunnel syndrome

300

1240

2.19

34.77

1.6

1.4

5.94

5.77

u/l

0.17

254

1047

Persons encountering health services for other counselling and medical advice, not elsewhere classified

534

1655

1.85

34.76

1.4

1.5

5.07

5.93

u/l

3.54

460

1380

Cough

201

744

2.61

34.63

1.6

1.5

4.72

5.95

u/l

3.45

158

630

Methotrexate

209

4.30

34.58

2.0

1.2

5.73

5.63

u/l

0.05

182

Other disorders of adrenal gland

7.27

34.44

1.7

1.3

8.04

6.99

u/l

0.13

All pneumoniae

487

1806

1.87

34.33

1.6

1.4

6.47

5.79

u/l

0.60

401

1530

Hypertensive diseases (excluding secondary)

295

752

2.29

34.16

1.6

1.3

6.19

5.43

u/l

0.65

256

646

Other diseases of intestines

518

1633

1.85

34.13

1.4

1.5

5.43

6.17

u/l

1.18

433

1382

Cardiovascular diseases (excluding rheumatic etc)

343

926

2.15

34.08

1.5

1.4

6.25

5.47

u/l

0.72

293

787

Arthrosis

323

807

2.21

33.88

1.4

6.65

6.69

u/l

0.02

278

670

Pneumonias (Asthma/COPD co-morbidities)

483

1802

1.86

33.85

1.6

1.4

6.46

5.81

u/l

0.57

399

1523

Persons encountering health services in other circumstances, wide

574

1661

1.80

33.67

1.4

1.5

6.00

5.93

u/l

0.05

498

1384

Asthma/COPD (KELA code 203)

461

1729

1.89

33.64

1.5

5.19

5.93

u/l

2.57

377

1465

Sleep disorders (combined)

479

1688

1.87

33.36

1.5

1.4

6.04

5.90

u/l

0.13

413

1410

Irritable bowel syndrome

165

590

2.82

33.33

1.4

1.5

4.95

6.08

u/l

1.84

131

499

Implicit Sepsis

348

1322

2.05

33.11

1.5

1.4

7.37

5.62

u/l

1.03

290

1115

Other peripheral vascular diseases

144

5.02

33.11

1.4

1.5

5.78

6.02

u/l

0.10

125

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

471

1786

1.86

32.91

1.6

1.4

6.49

5.80

u/l

0.60

389

1513

Pneumonia, organism unspecified

429

1636

1.90

32.40

1.6

1.4

6.42

5.84

u/l

0.42

351

1390

Temporal arteritis

9.33

32.25

1.2

1.1

5.29

5.24

u/l

0.03

Any mental disorder

532

1468

1.82

32.16

1.5

1.4

6.01

5.86

u/l

0.12

457

1236

Psychiatric diseases

526

1447

1.83

32.12

1.5

1.4

6.10

5.83

u/l

0.22

457

1218

Systemic lupus erythematosus, unspecified

7.58

31.99

1.9

1.4

5.67

6.87

u/l

0.46

Abnormal findings on diagnostic imaging of lung

232

971

2.34

31.81

1.7

1.4

6.35

6.14

u/l

0.11

206

802

Certain infectious and parasitic diseases

473

1261

1.88

31.81

1.4

1.5

6.40

5.64

u/l

0.77

404

1071

Trochanteric bursitis

179

4.40

31.26

1.3

1.5

4.77

6.41

u/l

1.25

147

ILD, hospital admissions 3, with pneumonia sepsis

121

5.29

31.25

2.2

1.6

6.33

6.91

u/l

0.23

108

Diseases of the respiratory system

315

728

2.18

31.10

1.5

1.4

6.19

6.06

u/l

0.07

266

615

Diseases of the eye and adnexa

415

1071

1.95

30.72

1.5

1.4

5.14

6.37

u/l

2.87

351

922

Coxibs

134

211

3.40

30.71

1.5

6.89

7.04

u/l

0.03

114

173

Endocrine, nutritional and metabolic diseases

402

1044

1.97

30.70

1.5

5.93

5.88

u/l

0.03

338

884

Intracranial trauma

215

663

2.43

30.43

1.6

1.4

7.56

5.57

u/l

0.91

185

567

Muscular dystrophy

20.09

30.31

1.8

1.2

8.97

8.38

u/l

0.05

Other disorders of lacrimal gland

186

742

2.52

30.28

1.5

1.4

5.06

6.32

u/l

2.58

148

628

Disorders of eyelid, lacrimal system and orbit

396

1643

1.90

30.17

1.5

1.4

5.12

6.02

u/l

3.27

317

1380

Anxiety (asthma-related co-morbidities)

303

1154

2.08

29.90

1.4

1.5

5.90

5.59

u/l

0.16

251

990

Other heart diseases, wide

453

1533

1.84

29.86

1.5

1.4

5.99

5.79

u/l

0.19

388

1298

Other arrhythmias

319

1204

2.04

29.64

1.4

6.71

5.60

u/l

0.76

273

1021

Hypertension, essential

394

1168

1.93

29.53

1.5

1.4

6.26

5.97

u/l

0.19

341

993

Abnormalities of heart beat

165

623

2.64

29.45

1.3

1.5

6.24

6.17

u/l

0.02

129

529

Obesity related asthma

180

721

2.51

29.08

1.6

1.4

5.61

6.27

u/l

0.90

156

621

Other arthrosis

225

691

2.34

28.96

1.5

6.43

6.98

u/l

0.24

182

574

520

1560

1.77

28.92

1.5

1.4

5.22

6.21

u/l

2.70

433

1304

All anxiety disorders

306

1212

2.04

28.88

1.4

1.5

5.91

5.92

u/l

0.00

253

1027

Complications of surgical and medical care, not elsewhere classified

452

1805

1.80

28.79

1.4

6.46

5.79

u/l

0.49

374

1511

Vocal cord dysfunction

151

4.46

28.78

1.7

1.1

5.91

6.46

u/l

0.25

127

Adrenocortical insufficiency

6.97

28.56

1.4

8.27

6.32

u/l

0.24

Gastrointestinal diseases

301

708

2.14

28.54

1.6

1.4

6.26

6.00

u/l

0.13

254

600

Immunodeficiencies

6.19

28.52

1.8

1.4

4.54

6.77

u/l

1.52

Oxicams

118

195

3.46

28.50

1.2

1.5

4.89

6.83

u/l

1.73

160

Other neurological diseases

328

1337

1.98

28.50

1.4

1.5

5.82

5.92

u/l

0.06

273

1128

Other localized connective tissue disorders

9.61

28.47

1.7

1.4

5.34

8.05

u/l

0.73

Migraine with aura

133

466

2.87

27.98

1.4

5.22

6.09

u/l

1.07

108

393

Hypothyroidism, drug reimbursement

156

4.02

27.89

1.4

1.3

6.53

5.08

u/l

1.06

142

Condition for Implicit Sepsis (Organ dysfunction codes)

392

1534

1.86

27.86

1.5

1.4

7.58

5.54

u/l

1.44

328

1303

Acute upper respiratory infections

475

1688

1.77

27.66

1.4

1.5

5.20

6.15

u/l

2.84

393

1413

Disorders of lacrimal system

210

924

2.29

27.52

1.6

1.4

4.98

6.07

u/l

2.79

170

782

Immunodeficiency with predominantly antibody defects

8.46

27.51

1.8

1.4

4.57

7.96

u/l

1.22

Bacterial infection, other or unspecified

245

1027

2.16

27.51

1.7

1.4

7.04

5.96

u/l

0.52

205

856

Migraine without aura

115

375

3.09

27.50

1.5

1.4

4.51

5.78

u/l

2.75

319

Concussion

182

642

2.46

27.44

1.6

1.4

7.09

5.59

u/l

0.60

157

550

Complications of medical and surgical care

335

1665

1.92

27.33

1.4

1.5

6.05

5.95

u/l

0.05

271

1400

Asthma-related pneumonia or sepsis

172

694

2.49

27.28

1.5

5.37

6.37

u/l

1.59

138

581

Asthma, hospital admissions 3, pneumonia

172

694

2.49

27.28

1.5

5.37

6.37

u/l

1.59

138

581

Giant cell arteritis with polymyalgia rheumatica

7.56

27.25

1.2

1.1

5.29

6.22

u/l

0.43

Spondylopathies (FG)

208

3.88

27.18

1.4

1.3

5.07

6.47

u/l

0.83

175

Asthma-related pneumonia

171

693

2.48

26.88

1.5

5.38

6.37

u/l

1.58

137

580

Hypertensive diseases

394

1199

1.87

26.67

1.5

1.4

5.97

5.95

u/l

0.01

341

1020

Hypertension

394

1199

1.87

26.65

1.5

1.4

5.97

5.95

u/l

0.01

341

1020

Urticaria and erythema

199

870

2.30

26.49

1.5

5.47

6.00

u/l

0.55

168

740

Polyarthrosis

269

3.37

25.74

1.2

1.7

5.05

6.76

u/l

1.71

220

Complications of procedures, not elsewhere classified

367

1737

1.83

25.63

1.4

1.5

6.39

5.74

u/l

0.40

309

1457

Other heart diseases

243

749

2.15

25.30

1.6

1.4

6.37

5.44

u/l

0.72

207

644

Disorders of lipoprotein metabolism and other lipidaemias

359

1211

1.87

25.11

1.5

1.4

6.30

5.89

u/l

0.31

312

1019

Coxarthrosis [arthrosis of hip](FG)

192

594

2.35

25.06

1.3

5.31

6.35

u/l

1.14

167

491

Weight loss

167

4.13

25.06

1.4

1.5

5.19

7.31

u/l

1.24

145

Other functional intestinal disorders

202

864

2.24

24.99

1.4

1.5

4.99

6.19

u/l

2.87

166

729

Visual disturbances

228

1082

2.12

24.81

1.4

1.5

5.96

6.11

u/l

0.06

180

925

Undetermined asthma

190

3.87

24.77

1.6

1.4

5.04

7.15

u/l

1.99

168

Hypothyreosis and Thyroxine purchase for inclusion criteria

421

1579

1.77

24.73

1.4

5.80

5.87

u/l

0.06

339

1328

Chronic sinusitis

214

992

2.17

24.70

1.7

1.4

4.99

5.97

u/l

2.87

184

853

Hypermobility syndrome

5.64

24.47

1.1

1.2

4.57

5.62

u/l

0.72

Other and unspecified nerve root and plexus disorders, also in other diseases

108

364

2.99

24.46

1.8

1.4

5.43

6.35

u/l

0.82

311

Hypothyroidism, other/unspecified

407

1519

1.77

24.34

1.4

1.5

5.82

5.79

u/l

0.02

326

1282

Follow-up examination after treatment for conditions other than malignant neoplasms

191

536

2.34

24.26

1.7

1.4

5.28

6.08

u/l

1.59

161

456

Osteopathies and chondropathies

255

1203

2.02

24.22

1.5

5.28

5.92

u/l

1.20

214

1023

Abnormal weight loss

150

4.26

24.20

1.4

1.5

5.22

7.50

u/l

1.21

132

Other diseases of upper respiratory tract

498

1535

1.70

24.16

1.6

1.4

5.54

6.03

u/l

0.80

406

1298

Undetermined asthma, excluding more controls

194

3.79

24.06

1.6

1.4

5.04

6.99

u/l

1.82

171

Sleep apnoea

419

1629

1.75

24.06

1.5

1.4

5.82

5.98

u/l

0.13

362

1371

Bronchitis

475

1846

1.69

24.03

1.5

1.4

5.35

6.07

u/l

1.88

399

1544

Other anxiety disorders

221

923

2.13

23.99

1.5

6.34

5.98

u/l

0.13

180

775

Extrapyramidal and movement disorders

174

751

2.33

23.93

1.4

1.5

5.42

6.30

u/l

1.13

145

626

Other disorders of urethra and urinary system

312

1233

1.90

23.92

1.4

1.5

5.89

5.81

u/l

0.05

258

1019

Disorders of the thyroid gland

428

1617

1.73

23.69

1.4

1.5

6.24

5.78

u/l

0.36

349

1362

Spondyloarthritis

308

3.14

23.66

1.3

5.03

5.77

u/l

0.66

264

Rash and other nonspecific skin eruption

170

3.99

23.64

1.6

1.5

7.63

6.15

u/l

0.25

143

Spondylolisthesis/Spondylolysis

278

3.26

23.63

1.6

1.5

4.85

6.71

u/l

2.28

238

Visual disturbances and blindness

234

1143

2.06

23.61

1.4

1.5

5.93

6.06

u/l

0.05

183

972

Non-selective monoamine reuptake inhibitors

183

786

2.27

23.56

1.4

4.90

5.87

u/l

2.49

154

662

Other diseases of urinary system

461

1522

1.71

23.41

1.3

1.5

5.98

5.96

u/l

0.01

383

1278

Radiculopathy

231

3.49

23.36

1.3

1.6

5.05

6.50

u/l

1.82

193

Seropositive rheumatoid arthritis

102

341

3.00

23.30

1.8

1.3

5.30

6.29

u/l

0.76

277

Sleep apnoea, including avohilmo

438

1661

1.72

23.30

1.5

1.4

5.77

6.01

u/l

0.22

380

1392

Rheumatoid arthritis, including avohilmo

193

881

2.20

23.24

1.8

1.4

5.48

5.97

u/l

0.73

164

734

Gonarthrosis

263

741

2.04

23.20

1.4

1.5

5.96

6.73

u/l

0.64

220

614

Diarrhoea and gastroenteritis of presumed infectious origin

319

1576

1.85

23.08

1.4

1.5

5.35

6.01

u/l

1.52

262

1330

Chronic rhinitis, nasopharyngitis and pharyngitis

164

704

2.34

22.87

1.3

1.5

5.28

6.28

u/l

1.84

128

619

Other bacterial diseases

416

1672

1.73

22.85

1.5

1.4

7.17

5.69

u/l

1.22

349

1414

Thyroiditis, ILD-related definition

197

3.69

22.83

1.4

1.3

4.65

5.89

u/l

0.79

168

Enlarged lymph nodes

255

3.32

22.70

1.5

1.3

7.90

6.30

u/l

0.34

213

Certain disorders involving the immune mechanism

117

430

2.75

22.65

1.7

1.5

5.21

6.41

u/l

1.45

370

Other disorders of skin and subcutaneous tissue

299

1471

1.87

22.55

1.8

1.4

6.00

5.88

u/l

0.07

244

1244

Disorders of conjunctiva

368

1761

1.76

22.26

1.4

1.5

5.22

5.91

u/l

2.12

305

1482

Symptoms and signs involving speech and voice

167

733

2.29

22.15

1.3

1.5

4.87

6.26

u/l

3.15

138

623

Brachial plexus disorders

179

3.79

22.02

1.2

1.5

5.00

6.99

u/l

1.27

156

Cerebral palsy and other paralytic syndromes

221

3.48

22.02

1.2

1.6

4.98

6.99

u/l

1.58

191

Intestinal infectious diseases

410

1881

1.70

21.92

1.4

1.5

5.50

6.02

u/l

0.96

339

1588

Implicit viral Sepsis

102

356

2.89

21.75

1.7

1.5

7.19

6.06

u/l

0.26

299

Viral Sepsis

102

356

2.89

21.75

1.7

1.5

7.19

6.06

u/l

0.26

299

Cerebral cysts

5.03

21.62

1.6

1.5

5.69

6.80

u/l

0.34

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

240

1197

1.97

21.49

1.6

1.4

6.34

6.22

u/l

0.04

191

1026

Heart failure, not strict

329

1255

1.81

21.42

1.7

1.4

7.03

5.83

u/l

0.80

274

1059

Osteoporosis

120

437

2.64

21.33

1.5

1.6

5.28

6.66

u/l

1.16

105

355

Conjunctivitis

339

1675

1.77

21.26

1.4

1.5

5.23

5.90

u/l

1.88

276

1414

Enthesopathies of lower limb, excluding foot

340

2.90

21.12

1.5

5.14

6.46

u/l

1.69

291

Non-allergic asthma (mode)

311

2.98

21.01

1.7

1.4

5.03

6.88

u/l

2.12

273

Factors influencing health status and contact with health services

142

273

2.62

21.01

1.4

8.10

6.46

u/l

0.55

121

229

Other disorders of fluid, electrolyte and acid-base balance

131

508

2.50

20.98

1.4

1.5

6.10

6.09

u/l

0.01

105

420

Non-allergic asthma (mode), excluding more controls

313

2.96

20.77

1.7

1.4

5.03

6.77

u/l

1.95

274

Acute sinusitis

243

1170

1.94

20.75

1.4

5.09

6.22

u/l

2.69

205

999

Acute upper respiratory infections of multiple and unspecified sites

327

1375

1.79

20.67

1.4

5.37

6.10

u/l

1.51

272

1167

Other specified/unspecified inflammatory spondylopathies

5.87

20.58

1.3

1.7

5.32

6.35

u/l

0.60

Other bursopathies

169

3.76

20.57

1.6

1.5

7.03

5.84

u/l

0.20

143

Other general symptoms and signs

5.59

20.56

1.4

5.63

7.06

u/l

0.62

Biological medication for rheuma

100

357

2.83

20.51

1.3

1.5

5.65

6.48

u/l

0.63

309

Other reaction to severe stress, and adjustment disorders

179

836

2.15

20.42

1.4

6.58

6.06

u/l

0.17

154

703

Migraine with aura and triptan purchases

312

2.94

20.09

1.4

1.5

5.18

5.66

u/l

0.54

269

Voice disturbances

139

589

2.38

20.06

1.4

1.5

4.91

6.02

u/l

2.20

115

501

Exclusions for E4_PCOS_BROAD

101

368

2.77

19.91

1.6

1.5

6.72

6.21

u/l

0.13

316

Constipation

374

1576

1.70

19.90

1.5

5.96

5.79

u/l

0.10

305

1336

Urticaria

158

711

2.24

19.80

1.5

5.54

5.81

u/l

0.21

131

602

Other extrapyramidal and movement disorders in other diseases

116

459

2.55

19.44

1.4

1.5

5.18

6.23

u/l

1.43

388

Hallux valgus (acquired)

137

410

2.43

19.42

1.4

1.6

5.00

6.17

u/l

1.58

119

343

Other diseases of pleura

188

802

2.09

19.40

1.9

1.5

8.12

5.97

u/l

0.96

163

666

Dental caries

126

513

2.45

19.40

1.8

1.4

6.38

5.93

u/l

0.18

106

436

Hypothyroidism, strict autoimmune, 3 medication purchases required

366

1468

1.71

19.35

1.4

1.5

5.64

5.82

u/l

0.15

295

1228

Other specified/unspecified soft tissue disorders

6.36

19.30

1.4

1.3

4.92

5.40

u/l

0.51

Pure hypercholesterolaemia

297

1103

1.81

19.27

1.4

7.25

5.98

u/l

0.76

252

928

Infections of the skin and subcutaneous tissue

256

1380

1.85

19.19

1.7

1.4

5.55

6.17

u/l

1.06

213

1180

Disorders of skin appendages

222

1148

1.94

19.15

1.5

6.02

5.82

u/l

0.10

182

976

Dentinal caries

114

448

2.55

19.14

1.9

1.4

6.37

6.06

u/l

0.10

378

Implicit bacterial Sepsis

162

685

2.18

18.81

1.5

8.52

5.87

u/l

0.85

136

569

Seronegative rheumatoid arthritis

148

3.81

18.71

1.7

1.3

5.74

7.17

u/l

0.57

123

Diaphragmatic hernia

166

782

2.13

18.58

1.6

1.5

5.69

6.25

u/l

0.52

130

657

Oxycodone

139

588

2.30

18.53

1.5

1.4

6.74

6.22

u/l

0.17

118

488

Selective serotonin reuptake inhibitors

421

1350

1.65

18.47

1.4

1.5

5.83

6.04

u/l

0.14

352

1133

Temporomandibular joint disorders, including avohilmo

200

1010

1.99

18.46

1.3

1.5

4.89

5.94

u/l

2.74

165

846

Psoriatic and enteropathic arthropathies

168

3.60

18.45

1.2

1.3

4.98

6.40

u/l

0.73

138

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

258

1417

1.82

18.27

1.4

1.5

6.21

6.09

u/l

0.05

212

1195

Sulfasalazine

118

486

2.44

18.16

1.3

1.2

4.90

5.84

u/l

1.60

412

Bacterial Sepsis

184

804

2.04

18.05

1.5

8.23

5.73

u/l

0.94

155

670

Diseases of oral cavity, salivary glands and jaws

394

1216

1.67

18.03

1.6

1.4

5.80

6.03

u/l

0.22

342

1011

Syncope and collapse

163

681

2.13

17.80

1.5

1.4

5.32

5.91

u/l

1.28

140

571

Coxarthrosis

182

596

2.08

17.66

1.3

1.5

5.35

6.59

u/l

1.66

159

494

Bacterial pneumonia (organism specified)

187

850

2.01

17.64

1.6

1.5

6.00

6.22

u/l

0.20

152

720

All influenza

120

505

2.39

17.63

1.9

1.5

6.93

5.86

u/l

0.29

434

Diseases of salivary glands

382

2.61

17.51

1.6

1.4

5.92

6.77

u/l

0.54

318

Bacterial pneumoniae

174

750

2.06

17.49

1.7

1.5

6.05

6.09

u/l

0.03

142

637

Other shoulder lesions

115

4.12

17.48

1.4

4.91

5.91

u/l

1.04

100

Neuralgia and neuritis, unspecified

5.57

17.45

1.6

1.5

5.84

6.21

u/l

0.23

Cystitis

357

1307

1.67

17.33

1.4

1.5

5.04

5.97

u/l

2.91

287

1082

Dentofacial anomalies [including malocclusion]

135

598

2.24

17.15

1.5

1.4

5.32

6.12

u/l

0.81

114

503

Pain and other conditions associated with female genital organs and menstrual cycle

105

403

2.51

17.08

1.3

1.5

4.64

5.82

u/l

1.78

328

Budesonide

197

3.27

17.02

1.6

1.1

5.80

5.83

u/l

0.01

168

Bacterial pneumonia, not elsewhere classified

166

712

2.07

16.91

1.7

1.5

6.08

6.12

u/l

0.04

135

607

Lupus erythematosus

6.39

16.82

1.8

1.3

5.01

7.53

u/l

0.74

Use of pramipexole

108

446

2.44

16.60

1.4

1.5

5.39

6.18

u/l

0.62

375

Other (seronegative) rheumatoid arthritis, wide

393

2.54

16.56

2.0

1.5

6.02

6.37

u/l

0.24

332

Benign neoplasms

422

1486

1.59

16.40

1.4

1.5

5.61

5.87

u/l

0.24

355

1259

Trigger finger

212

3.14

16.38

1.1

1.4

4.91

6.38

u/l

1.25

179

Allergic asthma (mode)

104

417

2.46

16.29

1.3

5.27

6.39

u/l

1.35

364

Disorders of parathyroid gland

374

2.55

16.21

1.3

1.6

4.81

6.08

u/l

2.16

308

Haemorrhage from respiratory passages

131

548

2.23

16.20

1.4

1.5

6.40

6.37

u/l

0.01

109

462

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

240

1345

1.79

16.15

1.3

1.5

6.18

6.05

u/l

0.05

199

1136

Fibroblastic disorders

311

2.71

16.14

1.4

5.37

5.63

u/l

0.29

260

Abnormal serum enzyme levels

127

562

2.24

16.12

2.0

1.4

6.30

6.72

u/l

0.28

112

480

Allergic asthma (mode), excluding more controls

104

419

2.45

16.12

1.3

5.27

6.32

u/l

1.24

366

Propionic acid derivatives

113

224

2.54

15.96

1.7

1.5

7.25

7.07

u/l

0.04

185

Benzodiazepine use

416

1901

1.56

15.74

1.4

6.38

5.80

u/l

0.36

332

1609

Acetic acid derivatives and related substances

105

211

2.60

15.67

1.3

1.5

7.00

7.04

u/l

0.01

173

Migraine without aura and triptan purchases

340

2.61

15.59

1.4

1.5

4.53

5.89

u/l

2.49

290

Benign neoplasms

353

1225

1.63

15.45

1.4

5.64

5.85

u/l

0.15

297

1036

Gingivitis and periodontal diseases

377

1209

1.61

15.37

1.6

1.4

5.87

6.02

u/l

0.13

328

1005

Zoster [herpes zoster]

321

2.64

15.22

1.5

1.6

5.34

6.50

u/l

1.00

274

Speech therapy

130

604

2.16

15.20

1.8

1.5

5.08

6.30

u/l

1.94

109

503

Subjective visual disturbances

118

531

2.24

14.94

1.3

1.5

4.82

6.44

u/l

2.39

452

Lateral epicondylitis

203

3.08

14.94

1.3

1.4

5.18

5.98

u/l

1.09

176

Tumor necrosis factor alpha inhibitors

319

2.62

14.89

1.2

1.6

5.16

6.66

u/l

1.36

274

Fenamates

146

3.11

14.83

1.2

1.5

5.10

5.70

u/l

0.47

120

Direct fill therapy

286

2.71

14.77

2.0

1.6

6.01

6.94

u/l

0.48

247

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

401

1760

1.55

14.72

1.5

1.4

5.47

5.96

u/l

0.87

335

1478

STROKE

242

954

1.77

14.66

1.5

1.4

6.47

5.60

u/l

0.42

201

808

Oter anti-inflammatory and antirheumatic agents, non-steroids

184

2.69

14.51

1.3

1.5

5.69

6.47

u/l

0.52

151

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

161

3.33

14.48

1.3

1.7

5.07

7.60

u/l

1.40

138

Other enthesopathy of foot (+metatarsalgia)

137

3.53

14.42

1.1

1.5

4.56

5.79

u/l

2.01

115

Diseases of arteries, arterioles and capillaries

257

1119

1.72

14.40

1.5

6.12

6.14

u/l

0.01

217

939

Psoriatic arthropathies

147

3.43

14.36

1.2

1.5

5.04

6.17

u/l

0.97

124

Postprocedural disorders of nervous system

143

3.47

14.26

1.4

5.06

6.08

u/l

0.71

119

Scoliosis

4.12

14.17

2.0

1.4

4.32

6.20

u/l

2.10

Paroxysmal tachycardia

103

373

2.35

14.16

1.4

1.3

5.72

5.77

u/l

0.03

317

Dental caries 1 and operation codes

359

1154

1.60

14.16

1.7

1.5

5.96

6.17

u/l

0.16

310

956

Ganglion

327

2.55

14.15

1.2

1.3

5.40

5.88

u/l

0.22

283

Symptoms and signs involving the urinary system

303

1437

1.63

14.14

1.4

1.5

6.32

6.00

u/l

0.15

244

1218

Internal derangement of knee

140

686

2.04

14.14

1.2

1.5

5.48

6.97

u/l

1.78

112

579

Other/unspecified enthesopathies, not elsewhere classified

102

3.95

14.12

1.3

1.4

4.96

6.19

u/l

1.08

Artrosis, including avohilmo

361

1251

1.59

14.00

1.4

1.5

6.35

6.21

u/l

0.08

315

1054

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

235

1344

1.72

13.96

1.4

1.5

5.17

5.83

u/l

1.61

189

1127

Accidents

370

1173

1.58

13.93

1.6

1.4

6.13

5.85

u/l

0.19

317

984

Other external causes of accidental injury

370

1173

1.58

13.93

1.5

1.4

5.89

5.85

u/l

0.04

318

984

Exposure to unspecified factor

394

2002

1.53

13.93

1.4

1.5

6.07

5.87

u/l

0.13

332

1678

External causes of morbidity and mortality

300

906

1.66

13.72

1.5

6.30

5.93

u/l

0.21

252

763

Endometriosis

161

484

1.99

13.56

1.3

1.4

4.81

5.81

u/l

1.73

131

391

Triptan medication for migraine, min. 3 purchases

250

1166

1.70

13.56

1.4

1.5

4.77

5.82

u/l

3.32

202

986

Other and unspecified urticaria

432

2.31

13.54

1.6

1.5

5.26

6.20

u/l

0.92

365

Functional dyspepsia

123

588

2.10

13.42

1.4

1.5

4.95

5.83

u/l

1.74

106

494

Polyuria

100

440

2.29

13.41

1.5

5.32

6.29

u/l

0.73

372

Neuromuscular dysfunction of bladder

164

3.20

13.40

1.2

1.7

5.17

6.78

u/l

1.39

141

Cervicocranial syndrome

144

3.36

13.38

1.2

1.7

4.99

6.17

u/l

1.26

124

Adhesive capsulitis of shoulder

239

2.78

13.32

1.3

1.5

5.32

6.23

u/l

0.65

203

Chronic gastritis

113

525

2.16

13.27

1.6

1.5

5.14

5.86

u/l

1.44

436

Mycoses

123

594

2.08

13.08

1.4

1.5

5.82

6.10

u/l

0.22

101

505

Viral infections characterized by skin and mucous membrane lesions

178

975

1.83

13.04

1.5

5.42

6.12

u/l

1.19

145

841

Other diseases of hard tissues of teeth

262

1180

1.66

12.97

1.5

1.4

5.33

6.04

u/l

1.14

224

985

Asthma and allergy

197

2.92

12.84

1.4

5.38

6.47

u/l

0.83

174

Migraine, single triptan purchase ok & required. ICD-code if available is included

334

1449

1.56

12.77

1.4

1.5

4.85

5.98

u/l

3.94

278

1235

Triptan medication for migraine, single purchase ok

334

1449

1.56

12.77

1.4

1.5

4.85

5.98

u/l

3.94

278

1235

Papulosquamous disorders

168

913

1.85

12.68

1.3

1.5

5.34

6.10

u/l

1.34

145

773

Allergic conjunctivitis

241

1431

1.66

12.57

1.4

1.5

5.17

5.79

u/l

1.58

194

1200

Diverticular disease of intestine

268

1085

1.64

12.56

1.6

1.4

5.49

6.11

u/l

0.53

225

920

Dental caries 3 and operation codes

371

1238

1.54

12.55

1.6

1.5

5.86

6.10

u/l

0.21

324

1028

Nausea and vomiting

104

470

2.18

12.53

1.6

1.5

5.29

6.52

u/l

1.37

390

Implicit fungal Sepsis

5.30

12.52

1.1

1.3

5.72

5.83

u/l

0.03

Hyperparathyroidism

319

2.46

12.51

1.3

1.6

4.86

6.24

u/l

1.99

261

Procreative management

149

655

1.93

12.43

1.3

1.6

5.74

6.08

u/l

0.34

123

560

Diseases of the ear and mastoid process

495

1732

1.45

12.43

1.5

1.4

5.85

5.94

u/l

0.08

409

1460

Missing teeth due to accident, extraction or parodontitis

204

2.87

12.40

1.4

1.5

6.06

7.20

u/l

0.48

168

Other disorders of teeth and supporting structures

418

2.26

12.33

1.4

5.50

6.34

u/l

0.72

344

Diseases of pulp and periapical tissues, including avohilmo

445

1570

1.48

12.32

1.6

1.4

5.73

6.05

u/l

0.41

387

1308

Renal tubulo-interstitial diseases

337

1682

1.54

12.30

1.5

6.78

5.66

u/l

0.86

275

1416

Asthma and allergy, excluding more controls

202

2.85

12.29

1.4

5.38

6.44

u/l

0.82

178

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

4.22

12.27

1.6

1.3

5.26

6.45

u/l

0.64

KRA_PSY_EATING, excluding more controls

122

3.46

12.27

1.4

5.94

5.95

u/l

0.00

100

Injuries to the knee and lower leg

476

1886

1.45

12.21

1.5

1.4

5.48

5.90

u/l

0.72

410

1567

Metatarsalgia

123

3.44

12.19

1.1

1.4

4.60

5.92

u/l

1.94

104

Neoplasms

335

1152

1.56

12.17

1.4

1.5

5.80

5.89

u/l

0.06

287

973

Other symptoms and signs involving cognitive functions and awareness

166

853

1.83

12.10

1.5

7.63

5.81

u/l

0.53

134

709

Fall on same level

474

1839

1.44

11.91

1.6

1.4

6.39

5.77

u/l

0.50

404

1542

Disorders of mineral metabolism

130

3.34

11.90

1.1

1.3

5.08

6.16

u/l

0.89

111

Adverse effects, not elsewhere classified

438

2.20

11.86

1.3

1.5

4.97

6.28

u/l

1.60

372

Dental pulpitis 1

443

1575

1.46

11.83

1.6

1.4

5.74

6.04

u/l

0.38

386

1312

Anti-inflammatory and antirheumatic products, non-steroids

102

224

2.29

11.79

1.7

1.5

7.64

7.07

u/l

0.12

185

Other hammer toe(s) (acquired)

227

2.66

11.76

1.6

1.8

5.43

7.07

u/l

1.23

185

Dental pulpitis 4

442

1573

1.46

11.74

1.6

1.4

5.74

6.04

u/l

0.37

385

1310

Other and unspecified effects of external causes

124

626

1.99

11.73

1.3

1.5

5.64

6.02

u/l

0.32

104

535

Hypo-osmolality and hyponatraemia

255

2.59

11.71

1.7

1.5

4.76

5.97

u/l

1.76

206

Restless leg syndrome

239

2.66

11.70

1.6

1.5

5.28

6.98

u/l

1.24

202

Other inflammation of eyelid

245

2.63

11.67

1.3

1.5

5.39

7.39

u/l

1.45

214

Falls/tendency to fall

464

1607

1.45

11.65

1.5

1.4

5.99

5.81

u/l

0.15

398

1351

Other diseases of the respiratory system

348

2.34

11.54

1.5

8.07

6.19

u/l

0.45

289

Other respiratory disorders and diseases

348

2.34

11.54

1.5

8.07

6.19

u/l

0.45

289

Renal failure

152

752

1.85

11.49

1.5

9.23

6.05

u/l

0.91

117

624

Other and unspecified drugs and medicaments

164

3.02

11.48

1.3

1.6

4.92

7.44

u/l

1.46

141

Other/unspecified enthesopathies of lower limb, excluding foot

3.81

11.46

1.1

1.7

4.71

6.15

u/l

1.60

Paracetamol of NSAID medication

118

2.83

11.44

1.6

1.5

7.97

7.21

u/l

0.16

Fungal Sepsis

4.71

11.44

1.1

1.4

5.68

5.89

u/l

0.07

Congenital malformations and deformations of the musculoskeletal system

169

2.97

11.39

1.5

1.6

5.66

6.50

u/l

0.44

144

Respiratory insufficiency

3.86

11.32

1.3

1.4

10.87

7.47

u/l

0.29

Benign neoplasm of colon, rectum, anus and anal canal

226

1243

1.65

11.25

1.6

1.4

6.16

5.96

u/l

0.10

183

1045

Personality disorders, excluding more controls

107

521

2.06

11.20

1.2

1.4

6.56

5.84

u/l

0.22

440

Other disorders of the musculoskeletal system and connective tissue

292

2.45

11.18

1.8

1.5

5.26

6.67

u/l

0.96

249

Dental pulpitis 4, only avohilmo

447

1621

1.44

11.11

1.5

5.65

6.11

u/l

0.70

391

1349

Injury, poisoning and certain other consequences of external causes

236

710

1.67

11.08

1.6

1.5

6.83

5.93

u/l

0.47

205

595

Cerebrovascular diseases (FINNGEN)

129

472

1.96

11.06

1.5

1.3

7.45

5.60

u/l

0.52

107

408

Reactive arthropathies, FINNGEN

3.78

11.01

1.4

1.3

5.78

8.00

u/l

0.58

Coagulation defects, purpura and other haemorrhagic conditions

400

2.21

11.01

1.6

1.5

5.41

6.37

u/l

0.83

342

Atopic dermatitis

219

1135

1.65

10.95

1.4

1.5

5.29

5.79

u/l

1.06

185

958

Diseases of pulp and periapical tissues

141

761

1.86

10.95

1.8

1.3

6.22

6.15

u/l

0.03

121

637

Rosacea

230

2.63

10.94

1.5

1.7

4.93

5.92

u/l

1.33

198

Ankylosing spondylitis

127

3.25

10.93

1.6

1.7

4.56

6.44

u/l

2.37

113

Hernia

370

1704

1.48

10.90

1.5

5.49

6.06

u/l

1.03

318

1440

Other and unspecified rosacea

170

2.91

10.80

1.6

1.7

4.91

6.06

u/l

1.43

147

Myasthenia gravis

6.37

10.79

1.0

1.2

4.97

6.80

u/l

0.52

261

2.51

10.78

1.6

1.4

5.23

6.19

u/l

1.06

218

Continuous positive airway pressure

280

2.35

10.69

1.3

1.4

5.40

5.83

u/l

0.46

238

Dental pulpitis 1, only avohilmo

446

1630

1.43

10.66

1.5

5.66

6.11

u/l

0.69

390

1358

Use of hypnotics and sedatives

429

1731

1.44

10.65

1.4

6.07

5.92

u/l

0.09

354

1467

Meniscus derangement

187

743

1.73

10.64

1.2

1.5

5.32

6.82

u/l

1.91

156

622

Psoriasis

125

657

1.91

10.57

1.2

1.5

5.41

6.09

u/l

0.87

110

557

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

146

3.04

10.50

1.4

1.5

5.20

6.61

u/l

1.11

126

Other and unspecified anaemias

147

788

1.81

10.46

1.4

1.5

6.81

6.02

u/l

0.31

114

658

Genitourinary diseases

254

792

1.61

10.44

1.5

1.4

6.91

5.91

u/l

0.64

226

678

Other anaemias

148

795

1.80

10.36

1.4

1.5

6.78

6.02

u/l

0.30

115

665

Behavioural syndromes associated with physiological disturbances and physical factors

137

746

1.84

10.36

1.3

1.5

7.69

5.66

u/l

0.91

115

636

Atrial fibrillation and flutter

130

444

1.92

10.27

1.5

1.3

6.99

5.69

u/l

0.53

111

383

Other diseases of blood and blood-forming organs, wide

479

2.06

10.21

2.0

1.5

6.80

5.89

u/l

0.64

405

Ischemic heart diseases

297

1220

1.53

10.21

1.5

1.4

7.24

5.70

u/l

1.12

258

1029

Codes for special purposes

178

1051

1.70

10.21

1.3

1.5

5.57

6.02

u/l

0.48

148

890

Noninfective enteritis and colitis

187

1118

1.68

10.19

1.6

1.4

6.01

5.92

u/l

0.05

155

956

Diseases of arteries, arterioles and capillaries (FINNGEN)

317

2.12

10.16

1.2

1.3

7.18

5.65

u/l

0.43

271

Etanercept

128

3.16

10.16

1.3

1.7

5.19

6.71

u/l

1.04

106

Gout

345

2.20

10.15

1.2

1.5

5.42

6.96

u/l

1.36

279

Faecal incontinence

145

2.99

9.98

1.2

1.3

5.45

6.08

u/l

0.26

117

Other symptoms and signs involving the digestive system and abdomen

314

2.31

9.98

1.7

1.4

5.50

6.90

u/l

0.77

261

Provisional assignment of new diseases of uncertain etiology

177

1051

1.69

9.95

1.3

1.5

5.57

6.02

u/l

0.48

148

889

Impingement syndrome of shoulder

372

2.19

9.92

1.3

1.4

5.33

5.99

u/l

0.67

324

TMD related operations

392

2.16

9.90

1.6

1.5

5.54

6.43

u/l

0.69

331

Aplastic and other anaemias

158

863

1.74

9.85

1.5

6.63

6.05

u/l

0.23

123

722

Nonorganic sleeping disorders, excluding more controls

335

2.25

9.83

1.3

1.4

8.51

6.02

u/l

0.61

289

Arthropathic psoriasis

231

2.53

9.83

1.2

1.6

5.49

7.06

u/l

0.97

194

Other disorders of patella

299

2.32

9.72

1.5

4.96

6.33

u/l

1.41

260

Disorders of calcium metabolism

3.51

9.62

1.1

1.3

5.39

6.63

u/l

0.71

Synovial cyst of popliteal space [Baker]

3.74

9.59

1.9

1.3

10.68

6.16

u/l

0.35

Benign neoplasm: Colon

187

1114

1.65

9.59

1.6

1.5

6.44

6.07

u/l

0.15

149

931

Hyperkinetic disorders, excluding more controls

134

2.99

9.53

1.5

5.27

6.29

u/l

0.56

111

Other diseases of lip and oral mucosa

315

2.27

9.48

1.3

1.4

5.54

6.87

u/l

0.89

261

Atrial fibrillation and flutter with reimbursement

100

315

2.04

9.41

1.7

1.3

7.41

5.48

u/l

0.67

271

Parkinson's disease, strict definition, excluding more controls

116

3.14

9.36

1.3

5.99

6.23

u/l

0.06

Dental operations

245

799

1.58

9.33

1.5

1.4

6.12

6.52

u/l

0.24

215

649

Other and unspecified visual disturbances

168

2.76

9.27

1.6

1.4

9.32

7.42

u/l

0.17

142

Inflammatory diseases of female pelvic organs

240

1167

1.55

9.26

1.4

1.5

4.99

5.38

u/l

1.01

202

954

Covid-19 confirmed case

114

611

1.87

9.14

1.2

1.5

5.15

6.10

u/l

1.52

520

Postprocedural musculoskeletal disorders, not elsewhere classified

126

3.05

9.12

1.6

1.4

4.36

7.03

u/l

1.26

105

Dental operations, only avohilmo

265

884

1.54

9.09

1.5

5.94

6.58

u/l

0.47

233

723

Disorder of lipoprotein metabolism, unspecified

216

2.51

9.09

1.6

1.4

9.93

5.72

u/l

0.71

174

Reactive arthropathies

121

3.08

9.08

1.3

1.6

5.90

6.53

u/l

0.34

105

Conjunctivitis (acute, non atopic)

117

632

1.85

9.06

1.5

1.6

5.17

5.97

u/l

1.33

539

Other acute lower respiratory infections

196

1167

1.61

9.06

1.7

1.4

5.43

6.04

u/l

1.06

174

983

Diseases of liver

134

758

1.77

9.03

1.7

1.4

7.99

6.00

u/l

0.88

118

640

Viral pneumonia

211

2.53

9.02

1.5

5.31

6.49

u/l

0.91

187

Benign neoplasm of colon, rectum, anus and anal canal

213

960

1.59

8.98

1.6

1.4

6.24

5.57

u/l

0.38

174

822

Other disorders of eye and adnexa

291

2.28

8.97

1.4

1.5

5.59

6.32

u/l

0.47

245

Achilles tendinitis

155

2.79

8.89

1.7

1.6

5.53

6.16

u/l

0.57

135

Other gastritis (incl. Duodenitis)

450

2.01

8.87

1.4

1.5

7.14

6.00

u/l

0.30

381

Postprocedural endocrine and metabolic disorders, not elsewhere classified

237

2.42

8.85

1.5

5.54

5.65

u/l

0.05

201

Pain associated with micturition

219

2.48

8.85

1.2

1.5

4.82

6.66

u/l

1.47

185

Dental caries, including avohilmo

299

1028

1.49

8.84

1.6

1.5

6.00

6.22

u/l

0.15

258

848

Parkinson's disease, excluding more controls

130

2.94

8.80

1.3

6.05

6.17

u/l

0.03

103

Dental caries 1

299

1029

1.49

8.80

1.6

1.5

6.00

6.21

u/l

0.15

258

849

Other disorders of white blood cells

3.37

8.77

2.2

1.4

6.11

8.22

u/l

0.53

Chronic periapical parodontitis

412

2.05

8.74

2.2

1.4

5.83

6.55

u/l

0.43

342

Collagenous colitis

168

2.70

8.73

1.8

1.5

5.66

6.85

u/l

0.52

143

Panic disorder

301

2.24

8.72

1.5

1.4

4.90

6.11

u/l

1.57

250

Hypokalaemia

191

2.58

8.72

1.2

1.6

8.02

5.60

u/l

0.75

159

Other disorders of nervous system

119

3.05

8.70

1.3

1.6

5.23

8.52

u/l

1.34

101

Diabetic neuropathy

173

2.66

8.68

1.6

1.7

5.21

7.40

u/l

1.32

153

Benign neoplasm of other and ill-defined parts of digestive system

341

2.15

8.64

1.5

5.58

6.02

u/l

0.32

294

Other and unspecified coagulation defects

3.41

8.64

1.2

1.5

5.19

6.75

u/l

0.83

Dental pulpitis 2, only avohilmo

274

931

1.51

8.63

1.6

1.5

6.02

6.30

u/l

0.18

242

765

Other/unspecified rheumatoid arthritis

228

2.43

8.61

2.2

1.5

5.58

6.70

u/l

0.66

194

Dental pulpitis 2

269

912

1.51

8.59

1.5

1.4

6.10

6.32

u/l

0.13

238

747

Dental caries 1, only avohilmo

306

1065

1.47

8.56

1.6

1.5

6.17

6.34

u/l

0.11

264

882

Heart failure and antihypertensive medication

293

2.04

8.51

2.0

1.3

6.99

5.45

u/l

0.42

247

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

179

692

1.64

8.50

1.6

1.3

6.06

5.44

u/l

0.34

156

595

Chronic periodontitis

279

2.27

8.50

1.9

1.4

6.40

6.70

u/l

0.10

236

Venous thromboembolism

190

1162

1.59

8.50

1.7

1.4

6.12

5.95

u/l

0.09

170

968

Other nutritional deficiencies

250

1636

1.50

8.49

1.6

1.4

6.07

5.87

u/l

0.12

220

1368

Nutritional anaemias

171

1022

1.63

8.48

1.5

5.61

5.85

u/l

0.11

144

847

Other coagulation defects

132

2.90

8.43

1.7

1.4

5.10

6.21

u/l

0.78

109

Other metabolic disorders

255

2.33

8.43

1.5

1.4

5.53

5.57

u/l

0.02

216

Dental caries 3

319

1123

1.45

8.41

1.6

1.5

6.18

6.13

u/l

0.03

276

930

Plantar fascial fibromatosis

127

2.93

8.37

1.2

1.4

4.95

6.00

u/l

1.61

110

All influenza (not pneumonia)

294

2.22

8.34

1.8

1.5

5.23

6.17

u/l

0.86

253

Other noninfective gastroenteritis and colitis

523

1.90

8.33

1.7

1.5

5.46

5.96

u/l

0.51

440

Diplopia

245

2.34

8.25

1.4

1.5

4.95

6.90

u/l

1.64

210

Ischaemic heart disease, wide definition

282

1201

1.47

8.25

1.6

1.4

7.44

5.70

u/l

1.24

243

1016

Dental caries 3, only avohilmo

325

1154

1.44

8.22

1.6

1.5

6.20

6.24

u/l

0.02

283

957

Disorders of sclera, cornea, iris and ciliary body

208

1351

1.54

8.20

1.5

1.4

6.03

6.14

u/l

0.04

177

1153

Suggestive for eosinophilic asthma

168

2.64

8.19

1.5

5.64

7.67

u/l

1.04

147

Injuries to the wrist and hand

376

1966

1.39

8.18

1.4

1.5

5.68

5.96

u/l

0.36

316

1649

Benign neoplasm: Colon

182

871

1.61

8.16

1.6

1.4

6.45

5.61

u/l

0.41

146

743

Lesion of ulnar nerve

260

2.28

8.07

1.8

1.5

4.96

6.40

u/l

1.29

225

Hemiplegia

3.33

8.07

1.2

1.6

4.72

6.52

u/l

1.18

Algoneurodystrophy

3.68

8.03

1.3

1.4

5.55

6.77

u/l

0.46

Bipolar affective disorders

412

2.00

8.03

1.3

1.4

6.21

6.16

u/l

0.01

360

Dialysis, with operation codes

242

2.33

8.02

1.7

1.4

5.37

6.09

u/l

0.55

207

Explicit Sepsis

147

846

1.67

8.00

1.3

1.5

7.41

5.65

u/l

0.88

115

703

Generalized anxiety disorder

307

2.16

7.93

1.2

1.4

4.86

6.61

u/l

1.62

255

Ocular pain

154

2.68

7.89

1.2

1.7

5.45

6.07

u/l

0.39

132

Benign neoplasm of other and ill-defined parts of digestive system

354

2.07

7.88

1.5

1.6

5.58

6.34

u/l

0.51

304

Diseases of the digestive system

160

985

1.62

7.87

1.8

1.4

5.96

u/l

0.00

130

824

5-aminosalicylic acid

355

2.06

7.82

1.4

1.2

5.54

5.89

u/l

0.28

307

Injuries to the thorax

161

997

1.62

7.81

1.5

7.14

6.03

u/l

0.35

141

844

Ovarian cyst

146

497

1.70

7.80

1.6

1.4

4.69

5.80

u/l

2.10

123

400

Use of levodopa decarboxylase inhibitor

208

2.42

7.80

1.6

1.4

5.73

6.55

u/l

0.27

178

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

102

558

1.83

7.74

1.3

1.5

6.79

5.79

u/l

0.42

472

Hyperlipidaemia, other/unspecified

126

693

1.73

7.73

1.6

1.5

5.44

5.90

u/l

0.38

105

566

Other diseases of liver

384

2.02

7.72

1.8

1.5

5.50

6.30

u/l

0.62

326

Bleeding

295

1503

1.43

7.65

1.4

7.63

5.80

u/l

0.98

246

1271

Benign neoplasm: Stomach

174

2.55

7.65

1.3

1.6

6.08

6.64

u/l

0.18

146

Angina pectoris

210

926

1.53

7.63

1.4

5.95

5.59

u/l

0.45

180

771

Localized swelling, mass and lump of skin and subcutaneous tissue

118

678

1.75

7.62

1.5

5.62

6.12

u/l

0.52

102

573

Endometriosis of pelvic peritoneum

334

2.08

7.61

1.3

1.5

4.62

6.02

u/l

1.84

278

Acute renal failure

366

2.03

7.59

1.5

1.4

7.96

6.10

u/l

0.44

310

Traumatic subdural haemorrhage

121

2.86

7.58

1.8

1.2

11.95

5.79

u/l

0.48

101

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

114

651

1.76

7.52

1.4

1.5

4.92

6.04

u/l

2.11

561

Diagnoses used for exclusion with ILD

542

1.83

7.52

1.8

1.5

5.43

6.34

u/l

1.17

461

Other degenerative diseases of the nervous system

263

2.08

7.51

1.3

5.25

6.05

u/l

0.91

219

Hard cardiovascular diseases

285

1275

1.44

7.44

1.5

1.4

8.12

5.59

u/l

1.58

246

1071

Menorrhagia

141

460

1.70

7.43

1.5

1.4

4.68

5.83

u/l

1.85

116

374

Exclusions for E4_PCOS_CONSORTIUM

284

1244

1.43

7.30

1.3

1.5

5.86

5.67

u/l

0.15

239

1028

Deposits [accretions] on teeth

127

2.76

7.27

2.4

1.5

6.02

8.73

u/l

0.95

106

Other disorders of eyelid

145

861

1.63

7.25

1.4

1.5

5.05

6.22

u/l

2.55

114

711

Pneumocystosis

5.12

7.22

1.2

5.50

6.88

u/l

—

Gonarthrosis,primary

320

1440

1.40

7.22

1.4

1.5

5.78

5.97

u/l

0.19

270

1208

Disorders of lens

247

1063

1.47

7.21

1.6

1.4

6.16

5.93

u/l

0.14

213

891

Deviated nasal septum

121

712

1.70

7.18

1.4

7.58

6.57

u/l

0.22

615

Dermatophytosis

248

2.23

7.18

1.6

1.4

5.76

6.85

u/l

0.57

212

Nail dystrophy

8.00

7.17

1.0

1.3

6.08

8.46

u/l

—

Psoriatic arthropathies, ICD10

223

2.30

7.16

1.2

1.6

5.02

6.95

u/l

1.50

192

Disorders of vestibular function (Vertigo)

165

1045

1.57

7.12

1.3

1.5

6.18

5.94

u/l

0.14

133

880

Specific personality disorders

100

559

1.80

7.12

1.2

1.5

6.81

6.11

u/l

0.19

478

Unspecified privation

205

2.36

7.11

2.5

1.4

5.75

7.34

u/l

0.92

176

Adalimumab

199

2.38

7.10

1.1

1.6

5.02

6.89

u/l

1.77

168

Other viral diseases

118

691

1.71

7.08

1.8

1.5

5.55

6.03

u/l

0.63

599

Congenital malformations, deformations and chromosomal abnormalities

225

1469

1.47

7.07

1.5

5.06

5.98

u/l

2.30

185

1250

Thyroiditis

140

2.66

7.06

1.3

1.4

4.57

5.66

u/l

1.32

119

Cerebrovascular diseases

251

1242

1.45

7.05

1.5

8.22

5.85

u/l

1.03

199

1050

Nephropathy related operations

244

2.23

7.02

1.6

1.5

5.74

6.96

u/l

0.64

208

Persistent mood disorders

412

1.93

7.00

1.8

1.4

5.48

6.13

u/l

0.54

351

Benign neoplasm: Stomach

182

2.43

7.00

1.3

1.6

6.08

5.96

u/l

0.05

156

Female genital prolapse

118

391

1.75

6.94

1.3

1.4

5.14

5.88

u/l

0.71

321

Fracture of rib(s), sternum and thoracic spine

106

608

1.75

6.93

1.5

7.29

6.02

u/l

0.27

520

Other symptoms and signs involving the circulatory and respiratory systems

3.01

6.92

1.7

1.5

7.15

8.56

u/l

0.22

Pulmonary heart disease, diseases of pulmonary circulation

107

616

1.74

6.90

1.8

1.5

6.12

u/l

0.00

516

Excessive, frequent and irregular menstruation

152

520

1.63

6.89

1.5

1.4

4.69

5.76

u/l

1.93

123

418

Eating disorder

171

2.47

6.89

1.4

5.94

5.87

u/l

0.03

140

Acute bronchitis

145

887

1.61

6.85

1.7

1.5

5.54

6.15

u/l

0.78

127

747

Retention of urine

109

531

1.74

6.83

1.4

1.5

6.53

6.65

u/l

0.05

449

Septicaemia

134

791

1.63

6.77

1.3

1.5

7.77

6.08

u/l

0.70

104

652

Chronic kidney disease

503

1.81

6.65

1.5

1.4

9.32

6.06

u/l

0.52

418

Other skin changes

303

2.06

6.63

1.8

1.6

5.28

6.18

u/l

0.87

254

Pruritus

193

2.34

6.62

1.3

1.5

8.57

6.39

u/l

0.28

163

Injuries to the abdomen, lower back, lumbar spine and pelvis

135

833

1.61

6.55

1.5

6.84

6.06

u/l

0.19

111

700

Volume depletion

117

2.75

6.53

1.7

1.4

5.40

6.30

u/l

0.57

100

Candidiasis

265

2.12

6.52

1.3

1.6

5.51

6.55

u/l

0.65

225

Coeliac disease

252

2.15

6.52

2.6

1.5

5.27

5.95

u/l

0.68

223

Atypical facial pain

3.03

6.50

1.1

1.4

4.99

6.20

u/l

0.88

Cutaneous abscess, furuncle and carbuncle

568

1.75

6.50

1.7

1.5

5.60

6.17

u/l

0.57

494

Disorders of synovium and tendon in diseases classified elsewhere

4.90

6.47

1.5

1.3

3.92

5.38

u/l

2.04

Other cataract

151

742

1.58

6.46

1.8

1.5

6.50

6.29

u/l

0.08

130

613

Ulcer of lower limb, not elsewhere classified

227

2.21

6.45

2.1

1.4

5.30

6.24

u/l

0.95

189

Other and unspecified tonsillitis

125

645

1.65

6.45

1.6

1.5

5.20

6.55

u/l

1.91

106

564

Hernia of abdominal wall, postoperative

293

2.06

6.43

1.5

1.3

4.94

5.68

u/l

0.82

248

Asthma mixed form (mode)

3.31

6.41

1.2

1.3

4.95

6.29

u/l

0.78

Asthma mixed form (mode), excluding more controls

3.31

6.41

1.2

1.3

4.95

6.33

u/l

0.82

Paraplegia, diplegia of upper limbs

4.11

6.38

1.3

5.49

6.52

u/l

0.34

Post-traumatic stress disorder

136

2.59

6.36

1.4

4.80

6.19

u/l

1.25

111

Preparation and fitting of bite rail to mouth

322

2.00

6.34

1.6

1.5

5.90

6.64

u/l

0.41

276

Persons encountering health services in other circumstances

133

830

1.61

6.33

1.7

1.5

8.84

6.03

u/l

0.71

113

698

Purpura and other haemorrhagic conditions

249

2.14

6.30

1.5

1.6

5.58

6.91

u/l

0.82

217

Nail disorders

161

2.44

6.27

1.7

1.5

5.46

6.65

u/l

0.77

137

Childhood asthma (age<16), excluding more controls

144

2.38

6.26

1.6

1.5

4.94

6.34

u/l

0.90

121

Vasomotor and allergic rhinitis

139

868

1.58

6.22

1.6

1.5

4.86

6.08

u/l

3.13

116

749

Unspecified/other endometriosis

174

2.37

6.20

1.3

1.4

4.75

5.59

u/l

0.99

150

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

127

789

1.61

6.20

1.6

1.4

5.33

5.93

u/l

0.67

103

673

Exposure to other specified factors

271

1838

1.38

6.18

1.5

5.19

6.08

u/l

2.79

232

1550

Disorders of ocular muscles, binocular movement, accommodation and refraction

174

1152

1.50

6.16

1.4

1.5

5.07

5.98

u/l

2.52

136

988

Iron deficiency anaemia

139

875

1.58

6.15

1.5

1.4

5.92

5.79

u/l

0.04

115

724

Disorders of adult personality and behaviour

117

714

1.64

6.14

1.2

1.5

6.41

6.02

u/l

0.12

611

Chronic diseases of tonsils and adenoids

294

1353

1.38

6.12

1.4

5.44

5.88

u/l

0.59

258

1156

Urethritis and urethral syndrome

4.16

6.11

2.2

1.4

5.62

5.65

u/l

0.02

Childhood asthma (age<16)

146

2.34

6.09

1.6

1.5

4.94

6.31

u/l

0.89

123

Atopic dermatitis, strict definition with reimbursement

108

627

1.67

6.07

1.5

1.4

5.58

6.05

u/l

0.48

534

Disorders of choroid and retina

275

1450

1.38

6.02

1.6

1.4

5.87

5.97

u/l

0.05

230

1222

Special screening examination for infectious and parasitic diseases

320

1.85

5.98

1.2

1.3

6.78

6.12

u/l

0.18

279

Sarcoidosis

289

2.02

5.93

1.7

1.6

5.80

6.69

u/l

0.60

249

Vasculitis limited to skin, not elsewhere classified

4.05

5.91

1.4

1.2

5.19

8.10

u/l

0.82

Early onset COPD, excluding more controls

331

1.94

5.87

1.4

5.63

6.89

u/l

1.19

292

Enterocolitis due to Clostridium difficile

185

2.28

5.86

1.5

7.17

7.48

u/l

0.06

157

Superficial injury of lower leg

534

1.73

5.84

1.9

1.5

5.21

6.32

u/l

1.52

451

Amenorrhoea

113

2.67

5.82

1.5

1.8

6.18

6.01

u/l

0.07

Coronary atherosclerosis

229

1039

1.42

5.81

1.6

1.4

7.72

5.61

u/l

1.27

197

870

Other sleep disorders

186

2.27

5.79

1.2

1.5

6.97

6.71

u/l

0.06

163

Phobic anxiety disorders

251

2.08

5.79

1.5

1.4

9.89

6.79

u/l

0.28

206

Other septicaemia

116

704

1.62

5.78

1.4

1.5

8.36

5.92

u/l

0.96

579

Speech disturbances, not elsewhere classified

137

2.50

5.77

1.1

1.4

4.47

8.33

u/l

2.04

116

Transient ischemic attack

170

945

1.49

5.77

1.3

1.5

6.15

6.21

u/l

0.02

141

780

DVT of lower extremities and pulmonary embolism

137

880

1.56

5.75

1.8

1.4

5.88

6.13

u/l

0.15

121

729

Other and unspecified iron deficiency

109

665

1.64

5.75

1.6

1.4

4.89

5.99

u/l

2.28

554

Other bacterial intestinal infections

341

1.91

5.74

1.6

1.5

6.38

6.61

u/l

0.07

294

Bacterial intestinal infections, IBD co-morbidities

341

1.91

5.74

1.6

1.5

6.48

6.45

u/l

0.01

292

Cellulitis

463

1.78

5.74

1.6

1.5

5.28

6.29

u/l

1.23

401

Seropositive rheumatoid arthritis, wide

102

613

1.67

5.72

1.8

1.5

5.30

6.13

u/l

1.11

513

Cardiomyopathy, other and unspecified

150

2.42

5.70

1.6

1.4

6.13

6.38

u/l

0.11

122

Sleep disorders

472

1.76

5.68

1.3

1.5

8.89

5.82

u/l

0.89

403

Disturbance of activity and attention

179

2.27

5.66

1.5

5.36

6.28

u/l

0.49

150

Pneumonia due to other infectious organisms, not elsewhere classified

3.73

5.65

1.2

1.8

6.91

6.37

u/l

0.10

Injuries to the ankle and foot

253

1674

1.38

5.65

1.4

1.5

5.85

5.81

u/l

0.03

226

1412

Pulmonary embolism

577

1.69

5.64

1.8

1.5

6.23

6.21

u/l

0.01

481

Iridocyclitis

510

1.73

5.64

1.3

1.5

7.28

6.19

u/l

0.21

433

Protozoal diseases

3.58

5.62

1.3

1.4

5.54

6.45

u/l

0.36

Diseases of inner ear

184

1241

1.45

5.60

1.3

1.5

6.14

5.89

u/l

0.17

150

1046

Pulmonary heart disease

579

1.68

5.58

1.8

1.5

6.23

6.20

u/l

0.01

481

Acute tubulo-interstitial nephritis

206

1284

1.43

5.56

1.4

1.5

6.19

5.76

u/l

0.33

170

1075

Dermatographic urticaria

128

2.52

5.53

1.2

1.5

5.09

6.12

u/l

0.55

108

Type 2 diabetes, wide definition

287

1381

1.36

5.51

1.6

1.4

6.39

5.88

u/l

0.33

235

1164

Hypoparathyroidism

3.17

5.48

1.3

1.4

4.51

7.10

u/l

1.39

Disorders of orbit

2.92

5.47

1.7

1.3

5.38

6.85

u/l

0.79

Gout, FINNGEN

478

1.74

5.45

1.2

1.4

5.42

6.51

u/l

1.24

394

Infective dermatitis

218

2.12

5.40

1.2

1.6

4.73

7.10

u/l

1.89

186

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

138

905

1.53

5.35

1.4

1.5

5.75

5.68

u/l

0.04

121

770

Other psoriatic arthropathies

219

2.11

5.35

1.2

1.6

5.02

7.00

u/l

1.49

188

Misadventures to patients during surgical and medical care

273

1.99

5.34

1.3

1.6

6.63

6.70

u/l

0.02

239

Psoriasis vulgaris

415

1.79

5.34

1.3

1.5

5.69

6.42

u/l

0.54

355

Interstitial myositis

+∞

5.32

4.2

0.0

7.20

—

u/l

—

Ménière disease

174

2.25

5.32

1.2

1.5

5.12

7.31

u/l

1.23

152

Viral warts

200

2.16

5.30

1.7

1.5

6.31

7.57

u/l

0.51

170

Palmar fascial fibromatosis [Dupuytren]

187

2.20

5.29

1.7

1.4

5.54

5.65

u/l

0.07

159

Insulin, combination of fast acting with intermediate-acting or long-acting

206

1349

1.41

5.29

1.5

1.4

7.54

5.83

u/l

0.88

169

1142

Persons encountering health services in circumstances related to reproduction

217

1046

1.41

5.28

1.4

1.5

5.49

6.20

u/l

1.15

191

894

Nonorganic sleeping disorders

424

1.78

5.27

1.3

1.5

8.51

5.90

u/l

0.65

362

Sequelae of external causes of morbidity and mortality

536

1.68

5.26

1.9

1.5

5.34

6.41

u/l

1.25

453

Heart failure,strict

166

813

1.48

5.24

1.8

1.4

7.70

6.00

u/l

0.58

138

672

Other menopausal disorders

106

372

1.65

5.17

1.3

1.4

4.47

5.75

u/l

1.88

306

Eating disorders

202

2.14

5.17

1.3

1.5

5.91

5.66

u/l

0.13

167

Other/unspecified synovitis and tenosynovitis

145

2.35

5.14

1.4

5.18

6.27

u/l

1.33

125

Hyperkalaemia

3.19

5.04

1.6

1.3

4.68

5.39

u/l

0.61

Other/unspecified seropositive rheumatoid arthritis

605

1.62

5.00

1.7

1.5

5.33

6.12

u/l

1.01

506

Obesity and other hyperalimentation

223

1608

1.37

5.00

1.6

1.4

6.28

5.86

u/l

0.25

197

1345

Abnormal results of function studies

166

2.24

5.00

2.0

1.5

5.83

7.25

u/l

0.88

144

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

599

1.62

4.95

1.8

1.5

5.33

6.13

u/l

1.01

502

Senile cataract

212

941

1.40

4.93

1.5

5.65

6.08

u/l

0.59

181

780

Appendectomy

239

1702

1.35

4.88

1.4

5.45

5.86

u/l

0.67

202

1438

Artificial joint operation, meniscal resection

314

1596

1.31

4.86

1.4

5.31

6.19

u/l

2.07

265

1344

Statin medication

274

1146

1.34

4.86

1.5

1.4

6.47

5.62

u/l

0.63

239

967

Overexertion and strenuous or repetitive movements

208

2.08

4.83

1.6

1.5

5.76

7.55

u/l

0.96

177

Substance abuse, excluding more controls

175

1075

1.43

4.81

1.3

1.4

7.69

5.98

u/l

0.64

147

908

Other/unspecified reactive arthropathies

131

2.38

4.81

1.4

1.5

5.84

7.48

u/l

0.61

110

Dislocation, sprain and strain of joints and ligaments at neck level

341

1.83

4.81

1.4

1.5

5.68

6.60

u/l

0.59

292

Hyperkinetic disorders

199

2.09

4.80

1.5

1.4

5.32

6.25

u/l

0.54

166

False labour

116

465

1.57

4.80

1.2

1.5

4.78

5.42

u/l

1.29

104

383

Injuries to the head

390

1999

1.27

4.79

1.6

1.4

6.86

5.70

u/l

0.93

332

1671

Dislocation, sprain and strain of joints and ligaments of knee

218

1480

1.37

4.78

1.5

1.4

5.77

5.88

u/l

0.08

196

1247

Injuries to the shoulder and upper arm

283

1803

1.32

4.72

1.6

1.4

5.62

6.05

u/l

0.58

244

1515

Adenomyosis (Endometriosis of uterus)

279

1.91

4.71

1.2

1.5

4.87

6.24

u/l

1.32

232

Mouth breathing

146

998

1.47

4.71

1.5

6.72

6.14

u/l

0.15

124

863

Obesity

220

1603

1.36

4.68

1.6

1.4

6.32

5.86

u/l

0.26

194

1340

Other spirochaetal diseases

593

1.61

4.67

1.3

1.5

6.04

6.39

u/l

0.24

497

Spirochaetal infections, other/unspecified

165

2.20

4.65

1.1

1.4

5.11

7.45

u/l

1.24

140

Ankylosing spondylitis, ICD10

198

2.08

4.64

1.6

1.5

4.56

7.93

u/l

2.45

167

Strabismus

616

1.59

4.64

1.3

1.5

4.99

5.87

u/l

1.40

525

Insulin medication

206

1280

1.38

4.64

1.5

1.4

7.54

6.03

u/l

0.72

169

1087

Intracranial injury

188

1304

1.40

4.63

1.6

1.5

7.84

5.91

u/l

0.74

164

1100

Benign neoplasm: Colon, unspecified

473

1.68

4.58

1.8

1.5

5.48

6.41

u/l

1.04

394

Fracture of lumbar spine and pelvis

383

1.75

4.56

1.6

1.5

4.47

6.70

u/l

3.27

318

Unspecified misadventure during surgical and medical care

2.57

4.55

1.5

6.59

8.09

u/l

0.36

Personality disorders

107

692

1.55

4.53

1.2

1.5

6.56

6.05

u/l

0.15

591

Convulsions, not elsewhere classified

372

1.76

4.53

1.6

1.5

9.58

6.35

u/l

0.47

320

Other and unspecified disorders of vitreous body

134

905

1.48

4.51

1.5

5.05

6.13

u/l

2.27

114

757

Disorders of gallbladder, biliary tract and pancreas

347

1749

1.28

4.51

1.4

5.30

6.00

u/l

1.97

289

1464

Chronic laryngitis and laryngotracheitis

256

1.92

4.47

1.4

1.6

6.07

6.36

u/l

0.14

221

Inflammatory bowel disease

115

758

1.52

4.47

1.5

6.17

5.87

u/l

0.13

651

Complications of internal orthopaedic prosthetic devices, implants and grafts

409

1.72

4.45

1.3

1.7

5.55

6.23

u/l

0.58

339

Chronic pancreatitis

243

1.94

4.43

1.2

1.4

5.25

7.04

u/l

1.29

207

Anankastic personality disorder

2.71

4.42

1.1

1.4

4.69

6.81

u/l

1.40

Erysipelas

173

1127

1.40

4.39

1.4

6.82

5.91

u/l

0.42

154

947

Irregular menses

172

994

1.41

4.36

1.4

5.11

5.39

u/l

0.48

134

830

Abnormal findings on diagnostic imaging of other body structures

245

1.93

4.33

1.2

1.6

5.26

6.29

u/l

0.86

212

Trigeminal neuralgia

101

2.49

4.30

1.8

1.4

5.32

6.55

u/l

0.68

Inflammatory disease of uterus

310

1.81

4.29

1.2

1.5

4.81

5.37

u/l

0.68

258

116

727

1.50

4.27

1.6

1.5

5.27

6.41

u/l

1.82

593

Transplanted organ and tissue status

198

2.03

4.27

2.0

1.5

5.89

7.46

u/l

0.77

167

Polycystic ovarian syndrome, consortium definition

253

1152

1.33

4.26

1.5

1.4

4.95

5.40

u/l

1.13

198

954

Other and unspecified local infections of skin and subcutaneous tissue

178

2.09

4.26

1.3

1.5

4.48

7.83

u/l

2.46

155

Diseases of appendix

267

1867

1.30

4.25

1.4

5.83

5.95

u/l

0.11

218

1577

287

1.82

4.23

1.5

5.15

6.65

u/l

1.29

234

Other retinal disorders

198

1168

1.36

4.19

1.5

1.4

5.15

6.17

u/l

2.86

165

975

Cardiomyopathy

327

1.78

4.19

1.8

1.5

9.51

5.78

u/l

0.55

271

Fracture of skull and facial bones

478

1.64

4.17

1.6

1.5

6.39

6.19

u/l

0.08

422

Other disorders of ear

320

1671

1.28

4.15

1.5

1.4

5.81

6.03

u/l

0.16

264

1420

Tinnitus

533

1.60

4.15

1.5

4.94

6.37

u/l

2.21

462

Acute pancreatitis

397

1.69

4.08

1.4

1.5

5.23

6.70

u/l

1.64

338

Noninfectious colitis NAS

279

1.84

4.08

1.6

1.5

5.37

6.34

u/l

0.71

242

Vulvovaginal ulceration/inflammation in other diseases

110

2.38

4.07

1.5

1.3

5.71

5.55

u/l

0.08

Obsessive-compulsive disorder

110

2.38

4.06

1.5

1.3

6.03

6.65

u/l

0.25

Benign neoplasm: Colon, unspecified

487

1.62

4.06

1.8

1.4

5.48

6.09

u/l

0.67

407

Sequelae with surgical and medical care as external cause

406

1.68

4.04

1.9

1.6

4.96

6.23

u/l

1.57

344

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

102

672

1.52

4.02

1.5

1.4

5.59

6.01

u/l

0.46

576

Seborrhoeic dermatitis

176

2.06

3.99

1.4

1.5

4.94

7.73

u/l

1.76

151

Superficial injury of head

476

1.62

3.99

1.3

1.5

5.39

6.12

u/l

0.77

411

Acute appendicitis

247

1788

1.30

3.98

1.4

5.82

5.98

u/l

0.14

203

1518

Care involving dialysis

143

2.18

3.98

1.7

1.4

4.91

6.60

u/l

1.46

125

Atrophic disorders of skin

289

1.81

3.97

1.1

1.5

4.93

5.71

u/l

0.85

238

Appendicitis, broad definition

263

1861

1.29

3.96

1.4

5.79

5.95

u/l

0.14

215

1574

Valvular heart disease excluding rheumatic fever

147

758

1.42

3.91

1.8

1.4

7.33

5.92

u/l

0.49

118

634

Other and unspecified vasculitis limited to skin

3.46

3.91

1.3

1.2

5.26

8.21

u/l

0.78

Insomnia

357

1.71

3.91

1.3

1.5

9.30

5.89

u/l

0.74

306

Amyloidosis, other/unspecified

4.22

3.90

1.9

1.2

10.15

6.06

u/l

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

365

1.67

3.89

1.6

5.52

6.01

u/l

0.37

308

Disorders of vitreous body

154

1082

1.40

3.89

1.5

5.18

6.12

u/l

2.09

131

900

Heartburn

178

2.03

3.88

1.3

1.4

4.55

7.25

u/l

1.83

153

Emotionally unstable personality disorder

284

1.80

3.87

1.2

1.5

8.20

5.84

u/l

0.36

233

Non-rheumatic valve diseases

146

753

1.42

3.86

1.8

1.4

7.33

5.93

u/l

0.49

118

630

Other disorders of bone

465

1.62

3.86

1.4

1.5

5.29

6.31

u/l

1.16

399

Disorders of vitreous body and globe

157

1104

1.39

3.86

1.5

5.17

6.11

u/l

2.13

132

918

Injuries to the neck

512

1.59

3.85

1.4

1.5

5.69

6.22

u/l

0.41

439

Actinic keratosis

103

651

1.51

3.85

1.7

1.5

5.24

6.24

u/l

1.49

529

Major coronary heart disease event

224

1131

1.32

3.82

1.6

1.4

7.69

5.69

u/l

1.24

196

940

Other local infections of skin and subcutaneous tissue

193

1.98

3.82

1.3

1.5

4.46

7.58

u/l

2.50

169

Lyme disease

585

1.54

3.80

1.3

1.5

5.99

6.39

u/l

0.27

490

Blepharochalasis

585

1.54

3.80

1.6

1.5

5.31

6.47

u/l

1.49

487

Endometriosis ASRM stages 1,2

437

1.63

3.78

1.3

1.4

4.57

5.14

u/l

1.29

378

Other diseases of arteries and capillaries

153

2.10

3.78

1.3

1.5

5.56

6.81

u/l

0.70

135

Other inflammatory liver diseases

127

2.22

3.76

1.5

1.4

7.55

6.00

u/l

0.46

107

Unspecified acute lower respiratory infection

309

1.75

3.76

1.9

1.4

5.59

6.38

u/l

0.49

265

Insulin, intermediate and long-acting

174

1258

1.36

3.74

1.5

1.4

8.02

5.90

u/l

0.92

140

1061

Injury of muscle and tendon at lower leg level

317

1.74

3.73

1.5

5.19

7.04

u/l

1.87

277

Noninflammatory disorders of female genital tract

149

529

1.42

3.72

1.5

1.4

4.69

5.74

u/l

2.07

123

426

Atopic dermatitis, strict definition

105

694

1.49

3.72

1.5

5.57

5.97

u/l

0.42

591

Erosion of teeth, including avohilmo

431

1.62

3.71

1.3

1.4

5.22

5.59

u/l

0.42

366

Coxarthrosis, primary

178

1142

1.35

3.71

1.3

1.5

5.27

6.21

u/l

1.76

155

942

Other strabismus

500

1.58

3.71

1.3

1.5

4.94

6.12

u/l

1.73

432

Acute pancreatitis (for exclusion)

409

1.64

3.69

1.4

1.5

5.23

6.69

u/l

1.69

349

Diseases of male genital organs

172

631

1.38

3.68

1.5

1.4

7.09

6.73

u/l

0.12

154

548

Bell's palsy

203

1.93

3.66

2.1

1.5

5.35

6.96

u/l

1.03

172

Persons with potential health hazards related to communicable diseases

133

934

1.41

3.66

1.5

4.84

5.85

u/l

2.31

108

802

Unspecified fall

154

1110

1.38

3.65

1.7

1.5

7.38

5.98

u/l

0.45

129

944

Ulcerative colitis

575

1.53

3.65

1.5

1.4

5.58

5.98

u/l

0.36

489

Psychotic depression

2.38

3.64

1.7

1.6

4.98

6.85

u/l

1.09

Acute and subacute iridocyclitis

426

1.62

3.64

1.3

1.5

5.26

6.40

u/l

1.25

365

Chronic iridocyclitis

2.43

3.64

1.3

1.5

5.09

6.90

u/l

1.12

Acute appendicitis, no complications

195

1468

1.33

3.61

1.4

5.97

5.90

u/l

0.05

164

1260

Skin changes due to chronic exposure to nonionizing radiation

105

674

1.48

3.61

1.7

1.6

5.21

6.39

u/l

1.77

550

Parodontitis and operation codes

292

1799

1.26

3.60

1.6

1.4

5.73

6.03

u/l

0.34

256

1510

Chronic periodontitis, including avohilmo

306

1804

1.26

3.59

1.6

1.4

5.70

6.03

u/l

0.41

268

1513

Allergic contact dermatitis

284

1.77

3.58

1.2

1.5

5.06

6.32

u/l

1.03

244

Nasal polyp

374

1.66

3.58

1.4

5.45

6.51

u/l

1.02

320

Fracture of lower leg, including ankle

178

1322

1.34

3.58

1.6

1.4

6.59

6.00

u/l

0.20

152

1112

Major coronary heart disease event excluding revascularizations

201

1046

1.33

3.57

1.6

1.5

8.16

5.67

u/l

1.46

174

870

Gout, idiopatic and unspecified

436

1.61

3.57

1.3

1.4

5.30

6.45

u/l

1.44

367

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aldolase [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS